Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

H
h. Vahitov M.S.	-	SPECIFIC PHENOTYPE OF PLATELETS GPIB, GPIIB, GPIIIA AND GMP-140 IN PATIENTS WITH LOW LIMB VARICOSE VEIN DISEASE
Haaning J.	-	IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
Haas F.J.L.M.	-	THE CLINICAL VALIDATION OF A NEW QUANTITATIVE HIGH SENSITIVE D-DIMER ASSAY
Haas F.	-	QUANTIFICATION OF THE MEASUREMENT UNCERTAINTY FOR D-DIMER ASSAY RESULTS AROUND THE CUT-OFF LEVEL: IMPROVED DECISION RULES REQUIRED?
Haas F.J.L.M.	-	EVALUATION OF TWO SOLUBLE FIBRIN MONOMER ASSAYS
	-	THE USE OF THE ENDOGENOUS THROMBIN POTENTIAL ASSAY IN THE DIAGNOSIS OF DEEP VENOUS THROMBOSIS
Haas T.A.	-	A ROLE FOR 3 95105 IN FIBRINOGEN BINDING AND PLATELET AGGREGATION
Haas S.	-	CERTIFY, A PHASE III STUDY COMPARING CERTOPARIN WITH UNFRACTIONATED HEPARIN IN ELDERLY, ACUTELY ILL MEDICAL PATIENTS
Haas S.K.	-	EVALUATION OF VENOUS THROMBOEMBOLIC RISK PROFILES IN ACUTELY ILL MEDICAL PATIENTS IN HOSPITAL AND OUTPATIENT SETTINGS: THE STATUS REGISTRY
Habart D.	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	USE THROMBIN GENERATION ASSAY AND THROMBELASTOGRAPHY IN MONITORING OF RESPONSE TO DDAVP IN PATIENTS WITH TYPE 1 AND 2A VON WILLEBRAND DISEASE
	-	TEN NOVEL MUTATIONS IN FXI GENE
	-	KLF4, A MODIFIER GENE IN GP6-NULL MICE
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Haberichter S.L.	-	THE EFFECT OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR PROPEPTIDE LEVELS IN NORMAL INDIVIDUALS
Habermann R.	-	BIOMECHANICAL PROPERTIES OF VON WILLEBRAND FACTOR BINDING TO PLATELET GLYCOPROTEIN IB RECAPITULATED BY THE DIMERIC A1 DOMAIN
	-	ROLE OF DISTINCT AMINO ACID RESIDUES IN THE INTERACTION OF SOLUBLE OR SURFACE-BOUND VON WILLEBRAND FACTOR A1 DOMAIN WITH PLATELETS
Habes D.	-	ASSESSMENT OF THE PREDICTIVE VALUE OF PFA-100 TM OCCLUSION TIME CONCERNING THE HAEMORRHAGIC RISK OF TRANSPARIETAL NEEDLE LIVER BIOPSY IN CHILDREN
Habib F.M.	-	HAEMOSTATIC AND CYTOKINE CHANGES IN GESTATIONAL AND PREGESTATIONAL DIABETES MELLITUS
Habib A.	-	ELEVATED LEVELS OF CIRCULATING PROCOAGULANT MICROPARTICLES IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA
Hachelaf M.	-	A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY)
Hach-Wunderle V.	-	DIAGNOSTIC WORK-UP AND DIAGNOSTIC SAFETY IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS DATA FROM THE GERMAN TULIPA REGISTRY
	-	RISK PROFILE OF PATIENTS WITH DVT DIAGNOSED IN AMBULATORY CARE - DATA FROM THE GERMAN TULIPA REGISTRY
Hack C.E.	-	CELL-DERIVED MICROPARTICLES AND COMPLEMENT ACTIVATION IN PREECLAMPSIA VERSUS NORMAL PREGNANCY
Hack C.	-	VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK
Hackeng T.	-	PROTEIN S-C4BP COMPLEX STIMULATES ACTIVATED PROTEIN C-MEDIATED INACTIVATION AT R306 BUT INHIBITS INACTIVATION AT R506 IN FACTOR VA
Hackeng T.M.	-	MOLECULAR IMAGING OF THROMBI USING A BIMODAL A2-ANTIPLASMIN-BASED CONTRAST AGENT
Hackeng C.M.	-	COMPARISON OF A NEW CARTRIDGE* FOR THE PFA-100 WITH OTHER PLATELET FUNCTION ASSAYS FOR MEASURING THE EFFECT OF CLOPIDOGREL THERAPY IN CARDIOVASCULAR PATIENTS
	-	IMPAIRED EFFICACY OF CLOPIDOGREL IN PATIENTS WITH A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
	-	EVALUATION OF TWO SOLUBLE FIBRIN MONOMER ASSAYS
Hackeng T.	-	NOVEL FUNCTIONS OF PROTEIN S
Hacquard M.	-	INFLUENCE OF INJECTION SITE ON PROPHYLACTIC DOSE ENOXAPARIN BIOAVAILABILITY IN OBESE PATIENTS
Haddad R.	-	EVALUATION OF MILD HHCY IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN APOE-DEFICIENT AND NORMAL MICE
Hadipour M.	-	RARE COAGULATION DISORDERS IN ISFAHAN HEMOPHILIA CENTER
Haeberli A.	-	MONITORING THROMBIN GENERATION IN WHOLE BLOOD BY ELECTROCHEMISTRY - A NEW APPROACH FOR SCREENING THROMBOPHILIC AND HEMOPHILIC RISKS
	-	DEVELOPMENT AND VALIDATION OF A MULTIPLEXED FLUORESCENT BEAD-BASED IMMUNOASSAY FOR SIMULTANEOUS QUANTIFICATION OF COAGULATION AND FIBRINOLYSIS PARAMETERS IN HUMAN PLASMA
Haertlein B.	-	EFFECTS OF JNJ-28045446 ON P2Y12 ADP RECEPTOR FUNCTION IN VITRO AND IN VIVO
Hagedorn A.	-	DETERMINATION OF THE ANTICOAGULANT ACTIVITY OF IDRAPARINUX IN PATIENTS BY PROTHROMBIN-INDUCED CLOTTING TIME AND HEPTEST
Hagemeyer C.E.	-	MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
Hagiwara N.	-	OPTIMAL ANTICOAGULANT INTENSITY FOR JAPANESE PATIENTS WITH MECHANICAL VALVE
	-	THE RISK FACTORS FOR THROMBOEMBOLISM IN PATIENTS WITH MECHANICAL VALVE
Hagmüller G.W.	-	LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
Hague W.	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
Haider S.	-	USE OF RECOMBINANT ACTIVETED FACTOR VII FOR THE CONTROL OF POST PARTUM HEMORRHAGE: A CASE SERIES
Hajek R.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Hajifathali A.	-	FACTOR V MUTATIONS IN IRANIAN PATIENTS WITH ACTIVATED PROTEIN C RESISTANCE AND VENOUS THROMBOSIS
Hajjar K.A.	-	ANNEXIN 2 AND FIBRINOLYSIS
Hakamata Y.	-	INDUCTION OF FACTOR VIII SPECIFIC UNRESPONSIVENESS BY INTRATHYMIC FACTOR VIII INJECTION IN MURINE HEMOPHILIA A
Hakenberg O.	-	INCIDENCE AND DISEASE PATTERN OF VENOUS THROMBEMBOLISM AFTER RADICAL PROSTATECTOMY
Hakobyan N.	-	PRIMARY HUMAN SYNOVIAL CELLS PROLIFERATE IN RESPONSE TO HEMOGLOBIN AND WHOLE BLOOD
	-	THE IMPACT OF JOINT BLEEDING AND SYNOVITIS ON PHYSICAL ABILITY AND JOINT FUNCTION
	-	LOCAL INTRAARTICULAR EXPRESSION OF FACTOR IX FROM ADENO-ASSOCIATED VIRUS (AAV) VECTORS PREVENTS DEVELOPMENT OF HEMOPHILIC ARTHROPATHY
	-	FACTOR IX CONCENTRATED IN THE JOINT SPACE PROTECTS HEMOPHILIA B MICE FROM BLEEDING-INDUCED JOINT DETERIORATION IN THE ABSENCE OF CIRCULATING FACTOR IX
Halabi A.	-	EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR
Halaris A.	-	EFFECT OF ANTIDEPRESSANT DRUG TREATMENT ON INFLAMMATORY AND PLATELET ACTIVATION BIOMARKERS IN DEPRESSION
Halbmayer W.	-	A NEW,BI-DIRECTIONAL POINT-OF-CARE TESTING-NETWORK FOR THE INR DETECTION FROM CAPILLARY WHOLE BLOOD WITH A POSITIVE PATIENT IDENTIFICATION IN ORALLY ANTICOAGULATED OUT-PATIENTS
Halbritter K.	-	INCIDENCE AND DISEASE PATTERN OF VENOUS THROMBEMBOLISM AFTER RADICAL PROSTATECTOMY
Halbritter K.M.	-	RESULTS OF A ONE-YEAR REGISTRY OF BLEEDING COMPLICATIONS OF VITAMIN K ANTAGONIST THERAPY OUTSIDE A CONTROLLED POPULATION
Haley S.	-	EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT)
Haley P.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Halimeh S.	-	THE CHALLENGE OF PRAEOPERATIVE INVESTIGATION OF HEREDITARY AND ACQUIRED COAGULATION DISORDERS IN CHILDREN AND ADOLESCENTS
	-	PAEDIATRIC REFERENCE RANGES FOR COAGULATION DIAGNOSTICS
	-	NORMAL VALUES FOR FACTOR VII ACTIVITY IN NORMAL PREGNANCY AND IN THE PREGNACY OF WOMEN WITH CONGENITAL FACTOR VII DEFICIENCY
	-	FIVE NOVEL MUTATIONS IN F13B GENE RESULTING IN MILD FXIII DEFICIENCY
Halkier T.	-	IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
Hall M.	-	AGE-RELATED REFERENCE RANGES FOR TAFI AND FIBRIN MONOMERS IN HEALTHY CHILDREN
Hall A.J.	-	CHARACTERISATION OF ASE-LIKE ELEMENTS IN THE HUMAN PROTEIN Z GENE PROMOTER
Hall R.A.	-	THE TIGHT JUNCTION PROTEIN ESAM IS RECRUITED TO PLATELET-PLATELET CONTACTS AND FORMS SIGNALING COMPLEXES THAT AFFECT THROMBUS GROWTH AND STABILITY
Hall M.	-	AGE-RELATED REFERENCE RANGES FOR NEOPLASTINE R (PT) AND CEPHASCREEN (APTT) IN HEALTHY CHILDREN
Hallden C.	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Halter J.	-	PLATELET REFRACTORINESS DUE TO ANTI-HLA AND ANTI-HPA-5A ALLOANTIBODIES: CLINICAL MANAGEMENT DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Halton J.	-	POST-THROMBOTIC SYNDROME IN CHILDREN SURVIVING ACUTE LYMPHOBLASTIC LEUKEMIA
Hamacher J.	-	BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY
Hamad O.	-	FACTOR XII-MEDIATED CONTACT ACTIVATION OCCURS ON THE SURFACE OF THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP)-ACTIVATED PLATELETS
Hamada Y.	-	REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Hamada K.	-	ALTERNATION OF VON WILLEBRAND FACTOR AND ADAMTS13 ACTIVITY AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
Hamaguchi M.	-	DIFFERENTIAL DETECTION OF WILD-TYPE AND MUTANT MYH9 MRNA AND NMMHC-IIA POLYPEPTIDE REVEALS DOMINANT-NEGATIVE EFFECT IN GRANULOCYTES AND HAPLOINSUFFICIENCY IN PLATELETS IN PATIENTS WITH MYH9 DISORDERS
	-	ALLELIC FREQUENCY AND MINOR VARIATIONS OF THE FACTOR V R2 HAPLOTYPE IN JAPANESE POPULATION
Hamaguchi Y.	-	A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS
Hamaguchi M.	-	THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
Hamaia S.W.	-	CONSTITUTIVELY ACTIVE OR INACTIVE I DOMAINS AS PROBES FOR INTEGRIN BINDING TO COLLAGEN
	-	GENERATION OF INTERMEDIATE AFFINITY FORMS OF 2 I DOMAIN
Hamed M.	-	SUPERIOR EFFECT OF EPTIFIBATIDE ADDED TO CLOPIDOGREL ON BIOMARKER EXPRESSION DETECTED BY FLUOROKINE MULTI-ANALYTE PROFILING IN PATIENTS UNDERGOING ELECTIVE PCI
Hamid M.M.	-	THROMBIN GENERATION AMONG SUDANESE ESSENTIAL HYPERTENSION PATIENTS
Hamidou M.	-	SUCCESSFUL TREATMENT OF HIGH TITRE FACTOR VIII (FVIII) INHIBITOR IN TWO PATIENTS WITH MILD AND MODERATE HAEMOPHILIA A WITH RITUXIMAB ALONE
Hamidou S.R.	-	ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS RYTHMATOSUS
Hamilton J.R.	-	SELECTIVE SIGNALLING ROLE FOR PI 3-KINASE P110BETA IN THROMBIN-INDUCED CLOT RETRACTION
Hammarström P.	-	ACTIVATION OF FACTOR XII BY MISFOLDED PROTEIN AGGREGATES; IMPLICATIONS FOR CONTACT ACTIVATION
Hammelburger J.	-	ASSIGNMENT AND VALIDATION OF INR CONTROL AND CALIBRATOR SETS FOR LOCAL CALIBRATION OF INR
Hammer E.	-	PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES
Hammerstrøm J.	-	HOMOCYSTEINE AND RISK FOR VENOUS THROMBOSIS IN A POPULATION-BASED PROSPECTIVE STUDY (HUNT2)
Hammond S.	-	LABORATORY DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA: HELP OR HINDRANCE?
	-	CLINICAL DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Hamon M.	-	FONDAPARINUX REDUCED MAJOR BLEEDING VERSUS ENOXAPARIN IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING EARLY INVASIVE MANAGEMENT EVEN IN THE CONTEXT OF TRANS-RADIAL CORONARY INTERVENTION: INSIGHTS FROM OASIS-5
Hampshire D.J.	-	THE ISTH SSC VON WILLEBRAND FACTOR (VWF) ONLINE DATABASE
Hampton E.	-	ANTI XA ASSAYS FOR DANAPAROID: ASSESSMENT OF PRE ANALYTICAL AND ANALYTICAL VARIABLES
Hamsten A.	-	PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY
	-	ELEVATED LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION
Hamulyak K.	-	THE PROCOAGULANT EFFECTS OF PARTICULATE MATTER, A COMPONENT OF AIR POLUTION, IN THE LUNGS
Hamulyák K.	-	THROMBIN GENERATION IN PATIENTS AFTER RECENT DEEP VEIN THROMBOSIS VERSUS HEALTHY CONTROLS
	-	COMPARISON OF THROMBIN GENERATION AND FVIII LEVEL MEASUREMENTS IN HAEMOPHILIA PATIENTS AFTER RECOMBINANT FACTOR VIII TREATMENT
Hamulyak K.	-	ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION
Hamulyák K.	-	DOES THE PRESENCE OF MULTIPLE INHERITED THROMBOPHILIC DEFECTS EXPLAIN THE INCREASED RISK OF ARTERIAL THROMBOTIC EVENTS IN PATIENTS WITH PRIOR VENOUS THROMBOEMBOLISM?
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY
	-	HYPERHOMOCYSTEINEMIA IS NOT A RISK FACTOR FOR VENOUS AND ARTERIAL THROMBOSIS, BUT AN EPIPHENOMENON: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
	-	THROMBOPHILIC RISK FACTORS FOR FIRST VENOUS THROMBOEMBOLISM, RECURRENCE AND ITS IMPLICATIONS: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
	-	IN VIVO AVAILABILITY OF TWO RECOMBINANT FACTOR VIII PRODUCTS
	-	LEVELS OF FACTOR VIII (FVIII), D-DIMER AND THROMBIN GENERATION (TG) IN PATIENTS AFTER ACUTE DEEP VEIN THROMBOSIS (DVT)
Hamulyak K.	-	LOCALISATION OF COAGULATION PROTEINS WITHIN THE ARTERIAL VESSEL WALL IN RELATION TO PROGRESSION OF ATHEROSCLEROSIS
	-	THROMBIN GENERATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
Hamulyák K.	-	COAGULATION FACTORS AND THE PROTEIN C SYSTEM AS DETERMINANTS OF THROMBIN GENERATION
Hamulyak K.	-	THE NECESSITY OF CONTINUOUS INDIVIDUAL CALIBRATION IN CONTINUOUS FLUOROGENIC MEASUREMENT OF THE THROMBIN GENERATION CURVE
Hamulyák K.	-	THROMBIN GENERATION AND COAGULATION MARKERS IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION
	-	THROMBOXANE B2 IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION: THE INFLUENCE OF TREATMENT WITH ACETYLSALICYLIC ACID
Hamulyak K.	-	ACTIVE SITE INHIBITED FACTOR VIIA HAS A PROTECTIVE ROLE IN RENAL ISCHEMIA/REPERFUSION INJURY VIA ANTI-INFLAMMATORY MECHANISMS
	-	ACTIVE SITE INHIBITED FACTOR VIIA REDUCES MYOCARDIAL INFARCT SIZE AFTER ISCHEMIA/REPERFUSION INJURY IN MICE VIA TISSUE FACTOR/NFKAPPAB-MEDIATED MECHANISMS
Han W.	-	PRIMARY HUMAN SYNOVIAL CELLS PROLIFERATE IN RESPONSE TO HEMOGLOBIN AND WHOLE BLOOD
Han H.	-	ANTIPROLIFERATIVE ACTIVITY OF YQN1, A NEWLY SYNTHESIZED INDOLEDIONE DERIVATIVE, ON PDGF-BB-STIMULATED AORTIC VASCULAR SMOOTH MUSCLE CELLS
	-	CERAMIDE KINASE/CERAMIDE 1-PHOSPHATE IS AN IMPORTANT REGULATOR ON AORTIC VASCULAR SMOOTH MUSCLE CELL PROLIFERATION
	-	POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
Han I.	-	PROGNOSTIC SIGNIFICANCE OF THE POLYMORPHISMS IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR C677T) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) GENE IN EPILEPSY
Han Y.	-	ALTERATIONS OF HEMOSTATIC PARAMETERS IN PATIENTS RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Han K.	-	PLASMA LEVEL OF STROMAL DERIVED FACTOR-1 (SDF-1) IS INCREASED IN DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS WHO HAVE A POOR OUTCOME: IN VITRO EFFECT OF SDF-1 ON COAGULOPATHY
Han J.	-	COMPARISON OF LABORATORY DETECTION METHODS OF ASPIRIN RESISTANCE IN CARDIOVASCULAR DISEASE PATIENTS
	-	PLASMA LEVELS OF PROTHROMBIN FRAGMENT F1+2, D-DIMER, AND PROTHROMBIN TIME IN GASTRIC CANCER PATIENTS CORRELATE WITH CLINICAL STAGE AND LYMPH NODE METASTASIS
Han Z.	-	INTERFERON GAMMA +874A/T AND INTERLEUKIN-4 INTRON3 VNTR GENE POLYMORPHISMS IN CHINESE PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Hanada H.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Handa M.	-	HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AS A PLATELET SUBSTITUTE
	-	HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AND ENCAPSULATING ADENOSINE 5'-DIPHOSPHATE AS A PLATELET SUBSTITUTE
	-	A ROLE FOR GEMS IN PLATELET GLYCOPROTEIN IB-MEDIATED PLATELET ACTIVATION
	-	PROLONGED HEMOSTATIC ABILITY OF POLY(ETHYLENE GLYCOL)-MODIFIED POLYMERIZED ALBUMIN PARTICLES CARRYING FIBRINOGEN-GAMMA CHAIN DODECAPEPTIDE
Hanebutt F.L.	-	INFLUENCE OF DESMOPRESSIN ON HEMOSTASIS IN CHILDREN WITH BLEEDING DISORDERS
Hanley J.P.	-	USE OF RECOMBINANT FACTOR VIIA (RFVIIA) IN THE MANAGEMENT OF MAJOR HAEMORRHAGE - A SURVEY OF CURRENT UK PRACTICE
Hanley J.	-	GENETIC ANALYSIS IN HYPOFIBRINOGENEMIA IN ELEVEN FAMILIES
Hanna A.A.Z.	-	EFFICACY AND SAFETY OF A NOVEL HANSENULA POLYMORPHA -DERIVED RECOMBINANT RB-VARIANT HIRUDIN FOR THROMBOPROPHYLAXIS IN ORTHOPAEDIC PATIENTS
Hannes F.	-	EVALUATION OF THE COAGUCHEK XS PLUS SYSTEM IN A SWISS COMMUNITY SETTING
Hansen H.	-	ENHANCED THROMBUS FORMATION AFTER CHRONIC CHLAMYDIA PNEUMONIAE INFECTION IN A MURINE CAROTID ARTERY THROMBOSIS MODEL
Hansen J.B.	-	THE PREDICTIVE VALUE OF CRP, D-DIMER AND CLINICAL PROBABILITY TO EXCLUDE DVT IN PERSONS ADMITTED TO HOSPITAL FOR DVT
Hansen H.R.	-	HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
	-	CIRCULATING MATRIX GLA PROTEIN: A POTENTIAL MARKER FOR VASCULAR COMPLICATIONS OF TYPE 2 DIABETES MELLITUS
Hansen J.B.	-	ROLE OF LIVER SINUSOIDAL ENDOTHELIAL CELLS IN ELIMINATION OF HEPARIN
Hansen J.	-	MEAN PLATELET VOLUME (MPV) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
	-	FAMILY HISTORY OF MYOCARDIAL INFARCTION (MI) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
Hansen J.B.	-	ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PLASMA FROM PATIENTS WITH AMI DURING ANTITHROMBOTIC TREATMENT
Hanslik A.	-	MONITORING HEPARIN LEVELS IN CHILDREN DURING CARDIAC CATHETERIZATION: COMPARISON OF ACTIVATED CLOTTING TIME, ACTIVATED PARTIAL PROTHROMBIN TIME, AND ANTI-XA ACTIVITY
Hanson S.R.	-	PROTEIN C ACTIVATOR (PCA) INTERRUPTION OF THROMBUS PROPAGATION WITHOUT ANTIHEMOSTATIC SIDE EFFECT IN PRIMATES
	-	THE LEECH PRODUCT SARATIN IS A POTENT INHIBITOR OF PLATELET INTEGRIN ALPHA2BETA1 AND VWF BINDING TO COLLAGEN
	-	PROTEIN C ACTIVATOR (PCA) TREATMENT IMPROVES THE NEUROLOGICAL OUTCOME OF EXPERIMENTAL THROMBOTIC ISCHEMIC STROKE IN MICE
	-	HIGH SENSITIVITY THROMBOGENIC MARKER DETECTION IN THE INTRALUMINAL BOUNDARY LAYER
	-	IN VIVO ANTITHROMBOTIC ACTIVITY OF PROTEIN S (PS) THAT IS INDEPENDENT OF APC
	-	REDUCED MORTALITY OF PERITONEAL SEPSIS IN FACTOR XI DEFICIENT MICE
Hanss M.L.	-	A NOVEL DYSFIBRINOGENEMIA DETECTED BY ELECTROPHORESIS IN A PATIENT PRESENTING WITH FAMILIAL VENOUS THROMBOEMBOLISM
Hantel S.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
	-	THE ORAL DIRECT THROMBIN INHIBITOR, DABIGATRAN ETEXILATE, IS EFFECTIVE AND SAFE FOR PREVENTION OF MAJOR VENOUS THROMBOEMBOLISM FOLLOWING MAJOR ORTHOPEDIC SURGERY
	-	DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT
Hantgan R.R.	-	DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
	-	DIFFERENT INTEGRINS, DIFFERENT STATES, DIFFERENT SHAPES?
	-	THE VISCOELASTIC PROPERTIES OF SINGLE, CROSSLINKED AND UNCROSSLINKED FIBRIN FIBERS
Hanzawa K.	-	PLASMA D-DIMER CORRELATES WITH AGE, CAROTID ARTERIAL OR THORACIC AORTIC ATHEROSCLEROSIS
	-	THE RELATIONSHIP BETWEEN STRANDING IN CARS AND DVT AFTER THE MIDDLE NIIGATA PREFECTURE EARTHQUAKE 2004
	-	PREVALENCE OF DEEP VENOUS THROMBOSIS OR PULMONARY EMBOLISM (DVT/PE) IN PSYCHIATRY PATIENTS
	-	PREVALENCE OF DEEP VENOUS THROMBOSIS IN A YEAR AFTER THE MID NIIGATA PREFECTURE EARTHQUAKE
	-	RELATIONSHIP BETWEEN THE DIAMETER OF SOLEUS VEIN AND D-DIMER
Haramura G.	-	TRANSIENT ACTIVATION OF BLOOD COAGULATION FACTOR XIII BY POLYMORPHONUCLEAR GRANULOCYTE ELASTASE
	-	DOWN-REGULATION OF ACTIVATED FACTOR XIII BY POLYMORPHONUCLEAR GRANULOCYTE PROTEASES WITHIN THE FIBRIN CLOT
	-	TWO NOVEL MISSENSE MUTATIONS (THR233MET AND TRP308LEU) IN THE FACTOR X GENE AND THEIR FUNCTIONAL CONSEQUENCES IN A PATIENT WITH SEVERE FACTOR X DEFICIENCY
	-	PRODUCTION AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES AGAINST THE B SUBUNIT OF FACTOR XIII THAT INHIBIT THE FORMATION OF HETEROTETRAMERIC COMPLEX OF A AND B SUBUNITS
Harbrecht U.	-	D-DIMER LEVELS IN RELATION TO FACTOR V 1691 GENOTYPE AND ORAL ANTICOAGULATION. A CASE-CONTROL-STUDY OF 46 HOMOZYGOUS AND HETEROZYGOUS FACTOR V LEIDEN PATIENTS
	-	DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
	-	D-DIMER LEVELS IN RELATION TO FACTOR V 1691 GENOTYPE AND ORAL ANTICOAGULATION. A CASE-CONTROL-STUDY OF 46 HOMOZYGOUS AND HETEROZYGOUS FACTOR V LEIDEN PATIENTS
Harder S.	-	ARGATROBAN IN PATIENTS AFTER CARDIOVASCULAR SURGERY: INFLUENCE ON A THROMBIN GENERATION ASSAY
	-	FRACTALKINE RECEPTOR CX3CR1 EXPRESSION IN PLATELETS FROM PATIENTS WITH CARDIOVASCULAR DISEASE
Hardikar W.	-	CHANGES IN HAEMOSTATIC FACTORS DURING AND AFTER LIVER TRANSPLANTATION IN CHILDREN
	-	BLEEDING AND THROMBOTIC COMPLICATIONS OF LIVER TRANSPLANTATION IN CHILDREN
Hardy J.	-	THE COAGULOPATHY OF MASSIVE TRANSFUSION
Harel L.	-	THROMBOPHILIA DOES NOT INCREASE THE RISK FOR RECURRENT THROMBOSIS IN PEDIATRIC APS
Harenberg J.	-	DETERMINATION OF THE ANTICOAGULANT ACTIVITY OF IDRAPARINUX IN PATIENTS BY PROTHROMBIN-INDUCED CLOTTING TIME AND HEPTEST
	-	EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
	-	LONG LASTING ANTICOAGULANT EFFECTS OF ONCE WEEKLY SUBCUTANEOUS INJECTIONS OF IDRAPARINUX TO TREAT PATIENTS FOR PROPHYLAXIS OF RECURRENT VENOUS THROMBOEMBOLISM
Haris S.	-	METABOLIC SYNDROME IN ISCHEMIC STROKE PATIENTS' CHILD
Harper A.G.S.	-	A ROLE FOR TRPV1 IN THE ACTIVATION OF HUMAN PLATELETS
Harper J.	-	AN AUSTRALIAN EXPERIENCE OF RETRIEVABLE INFERIOR VENA CAVA FILTERS IN PATIENTS WITH INCREASED RISK OF THROMBOEMBOLIC DISEASE
Harper A.G.S.	-	A ROLE FOR THE NA+/CA2+ EXCHANGER IN STORE-OPERATED CALCIUM ENTRY IN HUMAN PLATELETS
Harper P.	-	CHARACTERISATION OF RZPI PRODUCED IN ESCHERICHIA COLI
Harper A.G.S.	-	A ROLE FOR DENSE GRANULE SECRETION IN POTENTIATION OF STORE-OPERATED CALCIUM ENTRY IN HUMAN PLATELETS
Harper J.	-	AN ASSESSMENT OF THE EFFECTIVENESS OF INFERIOR VENA CAVA FILTERS IN PREVENTION OF PULMONARY EMBOLISM BASED UPON DEMONSTRATION OF TRAPPED EMBOLUS AT THE TIME OF FILTER RETRIEVAL
Harper P.L.	-	ANTICOAGULANT MANAGEMENT USING AN INTERNET BASED MONITORING SYSTEM
Harrand R.	-	RECOMBINANT BBETA-LYS448 IS ASSOCIATED WITH SIGNIFICANT CHANGES IN FIBRIN STRUCTURE AND CLOT RIGIDITY
Harrington D.J.	-	VITAMIN K DEFICIENCY IN PATIENTS WITH CANCER REFERRED TO A HOSPITAL PALLIATIVE CARE TEAM
	-	URINARY EXCRETION OF VITAMIN K METABOLITES IN TERM AND PRETERM INFANTS
Harris S.A.	-	THE USE OF ADVATE IN LIVER AND KIDNEY TRANSPLANTATION IN A PATIENT WITH HEMOPHILIA A, HEPATITIS C, AND HIV
Harris J.E.	-	FUNCTIONAL CHARACTERIZATION OF PROLINE-RICH GLA PROTEINS (PRGPS) 1 AND 2
Harrison P.	-	LOW LEVELS OF PROTEIN Z ARE ASSOCIATED WITH AN INCREASED RISK OF RECURRENT VASCULAR EVENTS: A POPULATION-BASED STUDY
	-	LACK OF PREDICTIVE VALUE OF HIGH SHEAR PLATELET FUNCTION IN A POPULATION BASED COHORT STUDY OF ACUTE VASCULAR EVENTS
	-	LACTADHERIN IS MORE SENSITIVE THAN ANNEXIN-V AT DETECTING PHOSPHATIDYLSERINE EXPOSURE WITHIN PLATELETS
Harry Büller H.R.	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY
Harsfalvi J.	-	QUANTITATION OF VON WILLEBRAND FACTOR MULTIMER DISTRIBUTION BY DENSITOMETRY
	-	VWF FUNCTIONS, ADAMTS-13 ACTIVITY AND ANTIGEN LEVELS IN PATIENTS WITH LIVER CIRRHOSIS
	-	THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA
	-	POLYCYTHAEMIA VERA, ANTIPHOSPHOLPID ANTIBODIES AND ACQUIRED PLATELET FUNCTION ABNORMALITIES
Harthill J.E.	-	REGULATION OF PHOSPHODIESTERASE 3A IN HUMAN PLATELETS IS MEDIATED BY PROTEIN KINASE C
Hartig F.	-	UNEXPLAINED HIGH D-DIMER
Hartman D.	-	PLATELET EP3 RECEPTORS AS TARGETS FOR ANTITHROMBOTIC AGENTS - COMPARISON OF DG-041 WITH ASPIRIN AND AR-C69931
	-	EP3 RECEPTORS - A NEW TARGET FOR INHIBITION OF PLATELET AGGREGATION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
Hartwig J.H.	-	MECHANICS OF PROPLATELET ELABORATION
Harvey D.J.	-	IMPROVING PATIENT SAFETY WHEN STARTING WARFARIN IN THE HOSPITAL: THE WARFDOCS STUDY
Harvey E.J.	-	PROCOAGULANT EFFECT OF DEXAMETHASONE IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS: A POTENTIAL MECHANISM OF GLUCOCORTICOID-INDUCED OSTEONECROSIS
Harvey D.	-	VENOUS THROMBOEMBOLISM IN ACUTE LEUKEMIA PATIENTS: INCIDENCE, RISK FACTORS, AND MORTALITY
	-	CAUSE OF DEATH AMONG PATIENTS WITH LOCAL OR REGIONAL STAGE CANCER OF THE BREAST AND LUNG WHO DEVELOP VENOUS THROMBOEMBOLISM (VTE)
Harwardt M.	-	AN IN VIVO RISK/BENEFIT COMPARISON OF THE EFFECTS OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR WITH THROMBIN INHIBITORS, WARFARIN AND CLOPIDOGREL
	-	RECOMBINANT FACTOR VIIA PARTIALLY REVERSES THE EFFECTS OF THE FACTOR XA INHIBITOR RIVAROXABAN ON THROMBIN GENERATION, BUT NOT THE EFFECTS OF THROMBIN INHIBITORS, IN VITRO
Hashemi soteh M.B.	-	VON WILLEBRAND DISEASE TYPES 2A MUTATION (C.4789CT, P.R1597W) IN THREE IRANIAN PATIENTS
	-	VICENZA MUTATION R1205H IDENTIFIED IN TWO TYPE 1 VON WILLEBRAND DISEASE FAMILIES FROM ISRAEL
Hashemi Soteh M.	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Hashiguchi T.	-	HMGB1 PLAYS A CENTRAL ROLE IN ATHEROTHROMBOSIS
	-	HIGH-MOBILITY GROUP BOX 1 PROTEIN PROMOTES DEVELOPMENT OF MICROVASCULAR THROMBOSIS IN RATS
Hashimoto E.	-	IDENTIFICATION OF MULTIPLE SPLICE VARIANTS OF PHOSPHOLIPID SCRAMBLASE 1
Hashino S.	-	DISORDERS OF COLLAGEN-INDUCED AGGREGATION OF PLATELETS FROM CATTLE AND RATS WITH CHEDIAK-HIGASHI SYNDROME
Hassan T.	-	ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
Hassan J.	-	THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES
Hassan F.M.	-	THROMBIN GENERATION AMONG SUDANESE ESSENTIAL HYPERTENSION PATIENTS
Hasstedt S.J.	-	LINKAGE ANALYSIS FOR NORMAL PROTEIN C LEVELS IN A PROTEIN C-DEFICIENT FAMILY
Hatala P.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Hathcock J.J.	-	INHIBITORY ACTIVITY OF TISSUE FACTOR PATHWAY INHIBITOR BETA EXPRESSED BY E COLI AND EXPRESSION IN NORMAL HUMAN TISSUE
	-	PHOSPHOLIPID REGULATION OF COAGULATION REACTIONS
Hatipoglu O.N.	-	THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL
Hau C.M.	-	INHIBITION OF MICROPARTICLE RELEASE TRIGGERS ENDOTHELIAL APOPTOSIS
	-	SIMVASTATIN-INDUCED ENDOTHELIAL CELL DETACHMENT AND MICROPARTICLE RELEASE ARE PRENYLATION DEPENDENT
Hau C.	-	RETRANSFUSION OF PERICARDIAL BLOOD DOES NOT TRIGGER SYSTEMIC COAGULATION DURING CARDIOPULMONARY BYPASS
Hau C.M.	-	PLATELET MICROPARTICLES CONTAIN ACTIVE CASPASE 3
	-	COAGULANT PROPERTIES OF MICROPARTICLE-ASSOCIATED FUSION PRODUCTS OF FULL LENGTH AND ALTERNATIVELY SPLICED HUMAN TISSUE FACTOR WITH GREEN FLUORESCENT PROTEIN
Haubelt H.	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
Hauer A.	-	EFFECT OF SR-BI DEFICIENCY ON PLATELET AGGREGATION AND SUSCEPTIBILITY TO THROMBOSIS
Hauer R.	-	A NEW,BI-DIRECTIONAL POINT-OF-CARE TESTING-NETWORK FOR THE INR DETECTION FROM CAPILLARY WHOLE BLOOD WITH A POSITIVE PATIENT IDENTIFICATION IN ORALLY ANTICOAGULATED OUT-PATIENTS
Haumer M.	-	MONITORING HEPARIN LEVELS IN CHILDREN DURING CARDIAC CATHETERIZATION: COMPARISON OF ACTIVATED CLOTTING TIME, ACTIVATED PARTIAL PROTHROMBIN TIME, AND ANTI-XA ACTIVITY
Hauschner H.	-	A NATURAL MUTATION AND SPECIFIC ARTIFICIAL DELETIONS IN THE BETA3 CYTOPLASMIC TAIL PREVENT ANTIBODY-MEDIATED ACTIVATION OF INTEGRIN ALPHAIIB-BETA3
	-	IS BETA3-ARG261 RESPONSIBLE FOR THE EXCLUSIVE BINDING OF ALPHAIIB TO BETA3?
Hausdorf P.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Havelick J.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Havik S.R.	-	UNRAVELING THE MECHANISM OF INACTIVATION OF ACTIVATED TAFI
Havlikova K.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Hay C.R.M.	-	IN VIVO RECOVERY OF RISTOCETIN CO-FACTOR IN PATIENTS WITH VON WILLEBRAND DISEASE UNDERGOING PROCEDURES REQUIRING TREATMENT WITH HAEMATE P
	-	TRENDS IN FVIII AND FIX USE IN THE UNITED KINGDOM 2001-2006
Hay C.	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
	-	DETECTION OF PARTIAL F8 GENE DELETIONS IN HAEMOPHILIA A CARRIER DIAGNOSIS
Haya S.	-	INFLUENCE OF ADDING 4% BSA IN THE BETHESDA ASSAY FOR FACTOR VIII INHIBITOR QUANTIFICATION
	-	IDENTIFICATION OF DELETIONS IN WOMEN WITH FAMILY ANTECEDENTS OF SEVERE HAEMOPHILIA B BY MULTIPLE LIGATION PROBE AMPLIFICATION METHOD. COMPARISON WITH QUANTITATIVE REAL-TIME ASSAY
Hayashi A.	-	IDENTIFICATION OF MULTIPLE SPLICE VARIANTS OF PHOSPHOLIPID SCRAMBLASE 1
Hayashi J.	-	PLASMA D-DIMER CORRELATES WITH AGE, CAROTID ARTERIAL OR THORACIC AORTIC ATHEROSCLEROSIS
Hayashi A.	-	CLUSTERING OF SURFACE-BOUND BETA2-GLYCOPROTEIN I
Hayashi T.	-	REGULATION OF PROTEIN S EXPRESSION IN HEPATOCYTES AND SINUSOIDAL ENDOTHELIAL CELLS IN RATS WITH CIRRHOSIS
	-	LIPID RAFT-DEPENDENT ACTIVATION OF NOVEL 33-KDA SER/THR KINASE IN THROMBIN-STIMULATED PLATELETS
Hayashi J.	-	THE RELATIONSHIP BETWEEN STRANDING IN CARS AND DVT AFTER THE MIDDLE NIIGATA PREFECTURE EARTHQUAKE 2004
	-	PREVALENCE OF DEEP VENOUS THROMBOSIS OR PULMONARY EMBOLISM (DVT/PE) IN PSYCHIATRY PATIENTS
	-	RELATIONSHIP BETWEEN THE DIAMETER OF SOLEUS VEIN AND D-DIMER
	-	PREVALENCE OF DEEP VENOUS THROMBOSIS IN A YEAR AFTER THE MID NIIGATA PREFECTURE EARTHQUAKE
Hayashi T.	-	PHOSPHOINOSITIDE 3-KINASE-INDUCED CYTOSKELETAL TRANSLOCATION OF PROTEIN KINASE CK2 IN THROMBIN-STIMULATED PLATELETS
	-	REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Hayashida H.	-	INCIDENCE OF PULMONARY THROMBOEMBOLISM IN AUTOPSY CASES IN A JAPANESE GENERAL HOSPITAL
Hayward C.P.M.	-	NASCOLA SURVEY OF HIT TESTING IN NORTH AMERICA
	-	THE ROLE OF THE FACTOR V B DOMAIN IN FACTOR V-MMRN1 BINDING AND DISSOCIATION
	-	GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
	-	IDENTIFICATION OF A LOCUS FOR THE QUEBEC PLATELET DISORDER USING GENETIC LINKAGE ANALYSIS
	-	HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
	-	PLATELET FACTOR V DEFICIENCY IN A PATIENT WITH AN ACQUIRED INHIBITOR OF VA PROCOAGULANT FUNCTION
Hazelzet J.A.	-	ADAMTS13 AND VWF IN PEDIATRIC PATIENTS WITH SEVERE MENINGOCOCCAL SEPSIS
Hazenberg B.P.C.	-	ELEVATED PLASMIN-ALPHA2-ANTIPLASMIN LEVELS IN SYSTEMIC AMYLOIDOSIS INDICATE ACTIVATION OF THE FIBRINOLYTIC SYSTEM
Hcdc A.	-	CHALLENGES IN DEFINING TYPE 2M VON WILLEBRAND DISEASE: RESULTS FROM A CANADIAN COHORT STUDY
He Y.	-	COMPARISON OF EFFICACY AND SAFETY OF INTRAVENOUS AND INTRA-ARTERIAL THROMBOLYSIS IN ACUTE ISCHEMIC STROKE
He S.	-	FIBRIN GEL POROSITY: COMPARISON OF TWO LABORATORY ASSAYS
He L.	-	ACCELERATED ATHEROGENESIS AND NEOINTIMA FORMATION IN HEPARIN COFACTOR II DEFICIENT MICE
He X.	-	INFLUENCE OF BUYANG HUANWU DECOCTION COMBINED UNSATURAT FATTY ACID IN RATS WITH HYPERLIPIDEMIAED
He S.	-	INFLUENCE OF BUYANG HUANWU DECOCTION COMBINED UNSATURAT FATTY ACID IN RATS WITH HYPERLIPIDEMIAED
	-	EFFECT OF TETRAMETHYLPYRAZINE ON THE EXPRESSION OF TISSUE FACTOR INDUCED BY THROMBIN AND ITS MECHANISM
He X.	-	EFFECT OF TETRAMETHYLPYRAZINE ON THE EXPRESSION OF TISSUE FACTOR INDUCED BY THROMBIN AND ITS MECHANISM
He S.	-	INCREASED FIBRINOLYISIS ASSOCIATED WITH DEFECTIVE COAGULATION CONTRIBUTES TO IMPAIRMENT OF HEMOSTASIS IN HEMOPHILIA
	-	EFFECTS OF ARGATROBAN A THROMBIN INHIBITOR - ON THE FIBRIN GEL PERMEABILITY AND THE HEMOSTASIS BALANCE IN PLASMA
He X.	-	SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
He S.	-	SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
He S.L.	-	STUDY ON THE DETECTION AND APPLICATION OF THE LEVEL OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CEREBRAL INFARCTION
Head J.F.	-	CRYSTAL STRUCTURE OF THE C2 DOMAIN OF LACTADHERIN
Healey J.	-	NEUTRALIZING ANTI-FVIII ANTIBODIES HAVE A DIFFERENT IMPACT IN INHIBITING THROMBIN GENERATION
Healey J.F.	-	FUNCTIONAL CHARACTERIZATION OF STRUCTURAL EPITOPES IN THE C2 DOMAIN OF FACTOR VIII
Hebestreit H.	-	PLATELET PROINFLAMMATORY AND HEMOSTATIC FUNCTIONS IN PATIENTS WITH CYSTIC FIBROSIS
Hechler B.	-	VASCULAR WALL ALTERATIONS AND MATRIX EXPOSURE FOLLOWING LASER-INDUCED INJURY OF MOUSE MESENTERIC ARTERIOLES
	-	REDUCED ATHEROSCLEROTIC LESIONS IN P2Y1/APOE DOUBLE KNOCKOUT MICE
	-	IDENTIFICATION OF PF4 AND BETA-TG BY PROFILING AND LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OF SUPERNATANT PEPTIDES IN STORED APHERESIS AND BUFFY-COAT PLATELET CONCENTRATES
	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
	-	EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION
Heckbert S.R.	-	ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
	-	COAGULATION FACTORS IX - XIII AND RISK OF FUTURE VENOUS THROMBOSIS: THE LONGITUDINAL INVESTIGATION OF THROMBOEMBOLISM ETIOLOGY (LITE)
Heckel A.	-	DESIGN AND IN VITRO CHARACTERIZATION OF A PHOTODYNAMIC ANTICOAGULANT
Hedayatiasl A.	-	EPIDEMIOLOGY OF BERNARD SOULIER DISEASE
	-	EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
	-	THROMBOSIS IN BETA THALASSEMIA MAJOR
Heddle N.	-	HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
Heddle N.M.	-	GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
Hedenstierna G.	-	EFFECT OF MICROSPHERE EMBOLI ON THE VENTILATION-PERFUSION RELATIONSHIP IN THE RABBIT - A PILOT STUDY
Hedner U.	-	A WHOLE BLOOD CLOTTING METHOD MEASURING EX VIVO EFFECTS OF RFVIIA AND FVIII IN HAEMOPHILIA BLOOD
	-	RESTORING INITIAL THROMBIN GENERATION DOES NOT NORMALIZE CUTANEOUS WOUND HEALING IN HEMOPHILIA B
	-	HIGH DOSE FACTOR VIIA CORRECTS THROMBIN GENERATION IN A MODEL OF DILUTIONAL COAGULOPATHY
Heeb M.J.	-	RESIDUES 311-325 ON THE HEAVY CHAIN OF FVA REPRESENT AN ACTIVATED PROTEIN C BINDING REGION
	-	IN VIVO ANTITHROMBOTIC ACTIVITY OF PROTEIN S (PS) THAT IS INDEPENDENT OF APC
	-	PROTEIN S (PS) CONTAINS ZINC THAT IS ESSENTIAL FOR DIRECT ANTICOAGULANT ACTIVITY
Heeg B.	-	RECOMBINANT ACTIVATED FACTOR VII VS. ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE AS ON-DEMAND TREATMENT OF JOINT BLEEDS IN HEMOPHILIACS WITH INHIBITORS: A SYSTEMATIC LITERATURE REVIEW
Heegaard C.W.	-	RELATIONSHIP OF PROCOAGULANT ACTIVITY TO PHOSPHATIDYLSERINE EXPOSURE ON IMMORTALIZED ACUTE PROMYELOCYTIC LEUKEMIA CELLS
Heegard C.W.	-	LACTADHERIN IS MORE SENSITIVE THAN ANNEXIN-V AT DETECTING PHOSPHATIDYLSERINE EXPOSURE WITHIN PLATELETS
Heels-Ansdell D.	-	DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY
Heemskerk J.W.M.	-	INHIBITION OF P2Y12 BY AZD6140 REDUCES THROMBUS FORMATION AND PROCOAGULANT ACTIVITY ON COLLAGEN AND ATHEROSCLEROTIC PLAQUES
	-	DUAL EFFECT OF PLATELET-DERIVED MATRIX METALLOPROTEINASES ON OCCLUSIVE THROMBUS GROWTH
	-	FLOW-INDUCED THROMBUS FORMATION ON IMMOBILIZED COLLAGEN RECEPTOR-BINDING PEPTIDES
	-	CONTRIBUTIONS OF COLLAGEN AND GLYCOPROTEIN VI SIGNALLING IN THE INTRINSIC PATHWAY OF COAGULATION
	-	DETECTION OF ANTI-HAEMOSTATIC EFFECT OF PLASMA DILUTION VIA THROMBIN GENERATION
	-	SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
	-	VISUALIZATION OF THROMBUS FORMATION ON ACUTELY RUPTURED PLAQUES IN VIVO
Heeneman S.	-	VISUALIZATION OF THROMBUS FORMATION ON ACUTELY RUPTURED PLAQUES IN VIVO
	-	MOLECULAR IMAGING OF THROMBI USING A BIMODAL A2-ANTIPLASMIN-BASED CONTRAST AGENT
	-	LOCALISATION OF COAGULATION PROTEINS WITHIN THE ARTERIAL VESSEL WALL IN RELATION TO PROGRESSION OF ATHEROSCLEROSIS
	-	DUAL EFFECT OF PLATELET-DERIVED MATRIX METALLOPROTEINASES ON OCCLUSIVE THROMBUS GROWTH
Heep A.	-	INFLUENCE OF PERINATAL RISK FACTORS ON THE DEVELOPMENT OF PLASMATIC COAGULATION IN EXTREMELY PRETERM INFANTS
Heeskens J.	-	EVIDENCE FOR AN ALTERNATIVE REGULATION OF THE ACTIVITY OF THE BETA3-INTEGRIN ALPHAVBETA3 IN THE ABSENCE OF THE HIGHLY CONSERVED ALPHA-SUBUNIT GFFKR MOTIF
Heestermans A.A.C.M.	-	IMPAIRED EFFICACY OF CLOPIDOGREL IN PATIENTS WITH A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Hegadorn C.	-	THE EFFECT OF EXERCISE ON INDIVIDUALS WITH TYPE 1 AND TYPE 2B VON WILLEBRAND DISEASE (VWD)
	-	SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
Hegadorn C.A.	-	POLYMORPHIC AND MUTAGENIC SEQUENCE CHANGES IN THE A1 AND A2 DOMAINS OF VON WILLEBRAND FACTOR (VWF) RESULT IN ALTERATIONS TO ADAMTS13 CLEAVAGE EFFICIENCY
Hegadorn C.	-	IMMUNE TOLERANCE INDUCTION TO FVIII IN HEMOPHILIA A MICE USING SUBCUTANEOUSLY IMPLANTED FVIII GENE-MODIFIED ENDOTHELIAL PROGENITOR CELLS
Heger A.	-	THROMBIN GENERATION CAPACITY IS IMPAIRED IN METHYLENE-BLUE (MB) TREATED PLASMA UNITS COMPARED TO SINGLE-DONOR FFP, A PHARMACEUTICALLY LICENSED COAGULATION ACTIVE AND SOLVENT-DETERGENT (S/D) TREATED PLASMA PRODUCT AND A UNIVERSALLY APPLICABLE S/D-PLASMA UN
	-	A PHARMACEUTICALLY LICENSED SOLVENT/DETERGENT (S/D) TREATED PLASMA AND A UNIVERSALLY APPLICABLE DEVELOPMENT PRODUCT IN TTP AND HUS: QUANTIFICATION OF ADAMTS13 AND FACTOR H LEVELS
	-	A BIOCHEMICAL COMPARISON OF A PHARMACEUTICALLY LICENSED S/D TREATED PLASMA WITH A UNIVERSALLY APPLICABLE DEVELOPMENT PRODUCT AND SINGLE-DONOR FFPS SUBJECTED TO METHYLENE-BLUE DYE AND WHITE-LIGHT TREATMENT
Heguilen R.	-	LOW MOLECULAR THIOLS, PRO-COAGULANT STATE AND NATURAL ANTIOXIDANT SYSTEM IN HEMODIALYSIS PATIENTS
Heidinger M.	-	A NEW,BI-DIRECTIONAL POINT-OF-CARE TESTING-NETWORK FOR THE INR DETECTION FROM CAPILLARY WHOLE BLOOD WITH A POSITIVE PATIENT IDENTIFICATION IN ORALLY ANTICOAGULATED OUT-PATIENTS
Heijnen H.F.G.	-	PLATELET ARCHITECTURE IN THREE DIMENSIONS
Heikinheimo M.	-	FRESH FROZEN PLASMA DOES NOT ATTENUATE COAGULATION ACTIVATION AFTER NEONATAL CARDIOPULMONARY BYPASS
Heil S.G.	-	SINGLE AND COMBINED EFFECTS OF GENE VARIANTS ON PLASMA TOTAL HOMOCYSTEINE LEVELS: RESULTS OF A CANDIDATE GENE APPROACH IN A POPULATION SAMPLE
Heilmann C.	-	ACTIVATED PLATELETS ENHANCE THE ADHERENCE TO AND INVASION OF ENDOTHELIAL CELLS BY STAPHYLOCOCCUS AUREUS
Heindorfer A.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Heine G.H.	-	COUNTS OF CD14++CD16+ MONOCYTES PREDICT CARDIOVASCULAR EVENTS IN DIALYSIS PATIENTS
Heine S.I.	-	HEMOPHILIA A INHIBITOR AND AUTOIMMUNNEUTROPENIA: CASE REPORT
Heingärtner C.	-	UNEXPLAINED HIGH D-DIMER
Heiniger A.	-	NON-CATHETER SUPERIOR CAVA VEIN THROMBOSIS IN A PATIENT WITH HEMOPHILIA B AND HIGH TITRE INHIBITOR
	-	IMPACT OF FVIII PRODUCT CHANGE IN SEVERE HAEMOPHILIA A PATIENTS PREVIOUSLY TREATED WITH PLASMA-DERIVED FVIII
	-	ACQUIRED HEMOPHILIA IN AN HIV PATIENT
Heino J.	-	PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
Heinrich J.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Heinrichs C.	-	10-YEARS EFFICACY, SAFETY AND INHIBITORS IN ONE PLASMA-DERIVED FACTOR VIII CONCENTRATE
Heinsdorf S.	-	RAPID INCREASE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HAEMOPHILIA AND CHRONIC HCV- INFECTION
Heinzova V.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Heistad D.D.	-	REVERSAL OF HYPERCHOLESTEROLEMIA PROTECTS AGAINST ARTERIAL THROMBOSIS IN ATHEROSCLEROTIC MICE
Heistinger M.	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
Heit J.A.	-	LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
	-	QUALITY OF LIFE (QOL) EVALUATION IN WOMEN WITH MENORRHAGIA AND ABNORMAL HEMOSTASIS TESTING PARTICIPATING IN A CROSS-OVER STUDY OF INTRANASAL DESMOPRESSIN AND ORAL TRANEXAMIC ACID
	-	A HIGHLY-SENSITIVE PLASMA VON WILLEBRAND FACTOR (VWF):RISTOCETIN COFACTOR ACTIVITY ASSAY BY FLOW CYTOMETRY
	-	IMPACT OF VENOUS THROMBOEMBOLISM, VENOUS STASIS SYNDROME, VENOUS OUTFLOW OBSTRUCTION AND VENOUS VALVULAR INCOMPETENCE ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING: A POPULATION-BASED CASE-CONTROL STUDY
	-	VON WILLEBRAND FACTOR (VWF) MULTIMER ANALYSIS BY IN-GEL IMMUNOSTAINING AND INFRARED IMAGING
	-	RISK FACTORS FOR VENOUS THROMBOEMBOLISM (VTE) AMONG ACTIVE CANCER PATIENTS: A POPULATION-BASED CASE-CONTROL STUDY
	-	THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY
Hejazi S.	-	EPIDEMIOLOGY OF BERNARD SOULIER DISEASE
	-	GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
	-	EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
	-	THROMBOSIS IN BETA THALASSEMIA MAJOR
Heller C.	-	EXPERIENCES IN THERAPY AND OUTCOME OF ADOLESCENTS WITH ACUTE VENOUS THROMBOSIS
	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
Heller R.	-	THROMBIN STIMULATES AMP-ACTIVATED PROTEIN KINASE IN ENDOTHELIAL CELLS VIA A CAMKK-BETA-DEPENDENT PATHWAY
	-	SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
Heller C.	-	IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION
Heller P.G.	-	INVOLVEMENT OF THE TPO/MPL PATHWAY IN THE PATHOGENESIS OF INHERITED THROMBOCYTOPENIAS
Hellermann N.	-	THE Y2561 ALLELE OF A COMMON POLYMORPHISM IN THE C1 DOMAIN OF VON WILLEBRAND FACTOR APPEARS AS A NOVEL RISK FACTOR FOR MYOCARDIAL INFARCTION
Helley D.	-	PLATELET MICROPARTICLES LEVELS AND PREVALENCE OF ANTIPROTHROMBIN AND ANTI-BETA-2-GLYCOPROTEIN I ANTIBODIES IN THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)
	-	RISK FACTORS AND CLINICAL SIGNIFICANCE OF RESIDUAL PERFUSION DEFECTS AFTER SYMPTOMATIC PULMONARY EMBOLISM
	-	PLATELET MICROPARTICLES ARE A PREDICTIVE FACTOR OF OVERALL SURVIVAL IN PATIENTS WITH PROSTATE CANCER
	-	ARE VASCULAR ENDOTHELIAL GROWTH FACTOR PLASMA LEVELS A PREDICTIVE MARKER OF SUNITINIB RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA?
Hellgren M.	-	DALTEPARIN SHORTENS HUMAN LABOR
Hellinger J.	-	INFERIOR VENA CAVA FILTERS IN PEDIATRIC PATIENTS
Hellstern P.	-	FV LEIDEN, THE APOE GENOTYPE AND OTHER GENE POLYMORPHISMS IN PATIENTS UNDERGOING CARDIAC SURGERY
	-	PRESERVATION OF IN VITRO FUNCTION OF PLATELETS STORED IN THE PRESENCE OF A SYNTHETIC DUAL INHIBITOR OF FACTOR XA AND THROMBIN
Helmerhorst F.M.	-	EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY
Helms M.J.	-	PLATELET AGGREGATION AND SEROTONIN ACTIVITY
Hemker H.C.	-	DIFFERENTIAL EFFECTS OF CONVENTIONAL AND LOW DOSE ORAL HORMONE THERAPY, TIBOLONE AND RALOXIFENE ON FUNCTIONALITY OF THE ACTIVATED PROTEIN C SYSTEM
Hemker C.	-	THROMBIN GENERATING CAPACITY IS HIGHLY DECREASED AND DELAYED IN PATIENTS WITH VON WILLEBRAND DISEASE
	-	THE EFFECT OF DIRECT THROMBIN INHIBITORS (DTIS) IN CLOTTING PLASMA
Hemker H.C.	-	ORAL ANTICOAGULATION SEVERELY IMPAIRS THE FUNCTION OF THE PROTEIN C SYSTEM
Henary M.	-	MULTIMODALITY INTRAOPERATIVE IMAGING OF THROMBI IN THICK-WALLED BLOOD VESSELS OF LARGE ANIMALS USING NEAR INFRARED FLUORESCENCE
Hendler M.F.	-	MANAGEMENT OF SERIOUS HEMATOMAS IN PATIENTS ON CHRONIC ORAL ANTICOAGULATION: BALANCE BETWEEN IMMEDIATE AND LONG-TERM RISKS
	-	LOW MOLECULAR THIOLS, PRO-COAGULANT STATE AND NATURAL ANTIOXIDANT SYSTEM IN HEMODIALYSIS PATIENTS
	-	HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
	-	D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
Hendriks D.	-	PROCARBOXYPEPTIDASE U (TAFI) PLASMA LEVELS IN PATIENTS WITH HEREDITARY THROMBOPHILIA
	-	A PATIENT WITH A MAJOR CARBOXYPEPTIDASE N DEFICIENCY BUT WITH NORMAL PROCARBOXYPEPTIDASE U (TAFI) SERUM LEVEL
	-	PLASMA PROCPU (TAFI) AND CLOT LYSIS TIME ARE CORRELATED WITH CLOTTING FACTOR LEVELS AND THROMBIN GENERATION: A NOVEL APPROACH TO ASSESS THROMBOSIS RISK?
Hendriks D.F.	-	GENERATION OF CARBOXYPEPTIDASE U (TAFIA) IN ISCHEMIC STROKE PATIENTS RECEIVING THROMBOLYTIC THERAPY
Hendriks D.	-	SUBSTRATE SPECIFICITY STUDY OF CARBOXYPEPTIDASE U (TAFIA): DEVELOPMENT OF HIGHLY SELECTIVE CPU SUBSTRATES AS USEFUL TOOLS FOR ASSAY DEVELOPMENT
	-	TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
Hendriks D.F.	-	THE ZYMOGEN PROCARBOXYPEPTIDASE U (TAFI) DOES NOT INFLUENCE THE FIBRINOLYTIC RATE
Henrard S.	-	EVALUATION OF THROMBOPHILIA SCREENING IN WOMEN WITH OBSTETRICAL COMPLICATIONS: A "REAL WORLD" EXPERIENCE
Henry P.	-	CYP2C19*2 POLYMORPHISM INFLUENCES PLATELET FUNCTIONNALITY IN RESPONSE TO CLOPIDROGEL TREATMENT
	-	BIOLOGICAL INHIBITION OF PLATELET PROSTAGLANDIN PATHWAY IS NOT MAINTAINED BY LOW DOSE ASPIRIN THROUGHOUT 24 HOURS IN TYPE 2 DIABETIC PATIENTS
Henschen A.	-	PRONOUNCED B KNOB CAPACITY TO MODULATE FIBRIN ARCHITECTURE, STIFFNESS, AND PLASMIN LYSIS
Hepner M.D.	-	POST-INFECTIOUS PURPURA FULMINANS (PF): 12 YEAR-EXPERIENCE AT A SINGLE ARGENTINEAN CENTER
	-	USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN
	-	TYPE 2B VON WILLEBRAND'S DISEASE. REPORT FROM A SINGLE CENTER IN ARGENTINA
Heptinstall S.	-	HETEROCLITIN D, A COMPONENT OF PLANTS OF THE KADSURA SPECIES INHIBITS PAF-INDUCED PLATELET AGGREGATION, P-SELECTIN EXPRESSION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
	-	COMPETITION BETWEEN REVERSIBLE AND IRREVERSIBLE P2Y12 ANTAGONISTS AND ITS INFLUENCE ON ADP-MEDIATED PLATELET ACTIVATION
	-	COMPARISON OF THE EFFECTS OF THE P2Y14 RECEPTOR AGONIST UDP-GLUCOSE AND THE EP3 RECEPTOR AGONIST SULPROSTONE ON PLATELET FUNCTION
	-	PLATELET EP3 RECEPTORS AS TARGETS FOR ANTITHROMBOTIC AGENTS - COMPARISON OF DG-041 WITH ASPIRIN AND AR-C69931
	-	PLATELET AGGREGATION IS ENHANCED UNDER CONDITIONS OF HYPOTHERMIA
	-	RAISED LEVELS OF CD39 IN LEUCOCYTOSIS RESULT IN MARKED INHIBITION OF ADP-INDUCED PLATELET AGGREGATION VIA RAPID ADP HYDROLYSIS
	-	EP3 RECEPTORS - A NEW TARGET FOR INHIBITION OF PLATELET AGGREGATION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
	-	EFFECTS OF A FLAVANOL-RICH COCOA BEVERAGE ON PLATELET AND LEUCOCYTE FUNCTION IN MAN
	-	MEASUREMENT OF ENDOTHELIAL MICROPARTICLES IN BLOOD IS IMPAIRED IF CHYLOMICRONS ARE PRESENT AFTER A FATTY MEAL
Herault J.	-	REVERSIBLE BIOTINYLATED OLIGOSACCHARIDES: A NEW APPROACH FOR A BETTER MANAGEMENT OF THE ANTICOAGULANT THERAPY
	-	ANTITHROMBOTIC ACTIVITIES IN PHARMACOLOGICAL MODELS OF A LONG-ACTING REVERSIBLE SYNTHETIC OLIGOSACCHARIDE
	-	SULFATION OF THE 3-HYDROXYL GROUP OF THE REDUCING UNIT (H) ON ALKYLATED SULFATED PENTASACCHARIDE IS RESPONSIBLE FOR A HIGH AFFINITY FOR ANTITHROMBIN AND LONGER HALF LIFE IN ANIMALS
	-	SYNTHESIS AND PROPERTIES OF BIOTINYLATED ANTITHROMBOTIC OLIGOSACCHARIDES
	-	IN VITRO AND EX VIVO PROPERTIES OF LONG-ACTING REVERSIBLE OLIGOSACCHARIDES
Herbert J.	-	IN VITRO AND EX VIVO PROPERTIES OF LONG-ACTING REVERSIBLE OLIGOSACCHARIDES
	-	SYNTHESIS AND PROPERTIES OF BIOTINYLATED ANTITHROMBOTIC OLIGOSACCHARIDES
	-	SULFATION OF THE 3-HYDROXYL GROUP OF THE REDUCING UNIT (H) ON ALKYLATED SULFATED PENTASACCHARIDE IS RESPONSIBLE FOR A HIGH AFFINITY FOR ANTITHROMBIN AND LONGER HALF LIFE IN ANIMALS
	-	ANTITHROMBOTIC ACTIVITIES IN PHARMACOLOGICAL MODELS OF A LONG-ACTING REVERSIBLE SYNTHETIC OLIGOSACCHARIDE
Herbert A.	-	EFFECT OF SCLEROSANTS ON ANTITHROMBOTIC MECHANISMS, ENDOTHELIAL CELLS AND FIBRINOLYSIS
Herbert J.	-	REVERSIBLE BIOTINYLATED OLIGOSACCHARIDES: A NEW APPROACH FOR A BETTER MANAGEMENT OF THE ANTICOAGULANT THERAPY
Herczenik E.	-	ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS
Herishanu Y.	-	HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS
Hermann D.	-	PLATELET EP3 RECEPTORS AS TARGETS FOR ANTITHROMBOTIC AGENTS - COMPARISON OF DG-041 WITH ASPIRIN AND AR-C69931
	-	EP3 RECEPTORS - A NEW TARGET FOR INHIBITION OF PLATELET AGGREGATION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
Hermans P.	-	RECURRENT ARTERIAL THROMBOSIS WITH FACTOR V LEIDEN HOMOZYGOCY
Hermans C.	-	IMPACT OF PROPHYLACTIC ADMINISTRATION OF FFP ON HYPOFIBRINOGENEMIA IN PAEDIATRIC PATIENTS TREATED WITH L-ASPARAGINASE FOR ACUTE LYMPHOBLASTIC LEUKAEMIA
	-	ACUTE CORONARY STENT THROMBOSIS IN A PATIENT WITH SEVERE HAEMOPHILIA ON DUAL ANTIPLATELET THERAPY
Hermans C.R.	-	REPLACEMENT THERAPY WITH FIBRINOGEN CONCENTRATE: INDICATIONS AND ADEQUACY OF USE
Hermans C.	-	EVALUATION OF THROMBOPHILIA SCREENING IN WOMEN WITH OBSTETRICAL COMPLICATIONS: A "REAL WORLD" EXPERIENCE
	-	FINAL RESULTS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE PHARMACOKINETICS, EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15 NANOMETER-FILTERED PLASMA-DERIVED FACTOR VIII
	-	EVALUATION OF THE EFFECTS OF A SINGLE INFUSION OF FACTOR VIII ON WHOLE BLOOD COAGULATION THROMBOELASTOGRAPHY IN PATIENTS WITH SEVERE HAEMOPHILIA
	-	PROPOSITION FOR A MULTI-STEP MUTATION DETECTION IN HAEMOPHILIA A
Hermans C.R.	-	CURRENT PRACTICE IN THROMBOSIS AND HAEMOSTASIS: A SINGLE-CENTER RETROSPECTIVE STUDY
Hermans C.	-	DETERMINATION OF VKORC1 AND CYP2C9 GENOTYPES IS OF LIMITED VALUE DURING CHRONIC ANTICOAGULATION WITH ACENOCOUMAROL
	-	MONITORING AND DOSAGE MODULATION OF ENOXAPARIN DURING PREGNANCY
Hermeling S.	-	THE USE OF TISSUE-TYPE PLASMINOGEN ACTIVATOR TO DETECT MISFOLDED PROTEINS IN BIOPHARMACEUTICALS
Hermens W.T.	-	COMPARISON OF THROMBIN GENERATION AND FVIII LEVEL MEASUREMENTS IN HAEMOPHILIA PATIENTS AFTER RECOMBINANT FACTOR VIII TREATMENT
	-	IN VIVO AVAILABILITY OF TWO RECOMBINANT FACTOR VIII PRODUCTS
Hermida J.	-	AUTO-ANTIBODIES AGAINST EPCR AND THE RISK OF A FIRST DEEP VENOUS THROMBOSIS
	-	THROMBIN INDUCES MMP-10 IN HUMAN ENDOTHELIAL CELLS: PATHOPHYSIOLOGICAL IMPLICATIONS IN DISSEMINATED INTRAVASCULAR COAGULATION
Hermit M.B.	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
Hermus A.R.	-	CATECHOL-O-METHYLTRANSFERASE GENOTYPE IS ASSOCIATED WITH PLASMA TOTAL HOMOCYSTEINE LEVELS AND MAY INCREASE RECURRENT VENOUS THROMBOSIS RISK
Hernandez A.	-	TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 1 (TIMP-1) PREDICTS RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN END STAGE SYSTOLIC HEART FAILURE
	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Hernandez R.	-	SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK
Hernandez J.	-	MATRIX METALLOPROTEIN-9 IS ELEVATED IN BLOOD FROM PATIENTS WITH PULMONARY EMBOLISM AND RIGHT VENTRICULAR HYPOKINESIS ON ECHOCARDIOGRAPHY
Hernandez F.G.	-	CRYOPRECIPITATE-REMOVED PLASMA AS A SOURCE OF FACTOR IX IN THE TREATMENT OF HEMOPHILIA B
Hernández A.	-	INCREASED GENERATION OF ACTIVATED PROTEIN C ASSOCIATED WITH OBESITY. WEIGHT LOSS INFLUENCE
Hernandez Navarro F.	-	IMMUNE TOLERANCE INDUCTION WITH VIII-CONTAINING FACTOR VWF
Hernández-Espinosa D.	-	HEPARIN PROTECTS THE NATIVE CONFORMATION OF ANTITHROMBIN
Hernandez-Espinosa D.	-	IN VIVO EFFECTS OF HYPERTHERMIA ON THE FUNCTIONAL AND CONFORMATIONAL CHARACTERISTICS OF ANTITHROMBIN
	-	BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS
Hernández-Espinosa D.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Hernandez-Espinosa D.	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Hernández-Navarro F.	-	SURGERY IN HEMOPHILIA PATIENTS WITH INHIBITORS: REPORT OF 91 SURGICAL PROCEDURES
Hernandez-Navarro F.	-	RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS
Hernandez-Sampelayo P.	-	CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES
Herrenschmidt N.	-	EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION
Herrmann F.	-	GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY
	-	INHIBITOR OF FVII IN CONGENITAL SEVERE FACTOR VII DEFICIENCY
Hers I.	-	REGULATION OF PHOSPHODIESTERASE 3A IN HUMAN PLATELETS IS MEDIATED BY PROTEIN KINASE C
	-	TRANSACTIVATION OF THE INSULIN RECEPTOR MEDIATES PAR-1 RECEPTOR SIGNALLING TO P85 PI3 KINASE/PKB IN HUMAN PLATELETS
Hersemeyer K.	-	DOUBLE STRANDED RNA-MEDIATED MODULATION OF THE BALANCE BETWEEN TISSUE FACTOR AND THROMBOMODULIN ON THE ENDOTHELIUM: RELEVANCE FOR DYSFUNCTIONAL HAEMOSTASIS IN VIRAL INFECTIONS
	-	FACTOR VII ACTIVATING PROTEASE INHIBITS THE UROKINASE PLASMINOGEN ACTIVATION SYSTEM AND STIMULATES GELATINASES (MATRIX METALLOPROTEINASES-2 AND -9) IN VASCULAR SMOOTH MUSCLE AND ENDOTHELIAL CELLS
Herterich S.	-	CROSS-TALK OF VWF/GPIB- AND NO/CGMP-INDUCED SIGNALING IN HUMAN PLATELETS
Hertfelder H.	-	CATHETER-RELATED THROMBOSES IN NEWBORNS
	-	INFLUENCE OF PERINATAL RISK FACTORS ON THE DEVELOPMENT OF PLASMATIC COAGULATION IN EXTREMELY PRETERM INFANTS
	-	HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
Hertzberg B.	-	LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Herve C.	-	FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM
Herwald H.	-	NOVEL ROLE FOR TAFI IN THE MODULATION OF HOST RESPONSES BY STREPTOCOCCI?
Herzig R.	-	TISSUE PLASMINOGEN ACTIVATOR, PLASMINOGEN ACTIVATOR INHIBITOR-1 AND VON WILLEBRAND FACTOR IN THE ACUTE AND CONVALESCENT PHASE OF ISCHEMIC STROKE
Herzog S.	-	FACTOR V LEIDEN PROTECTS AGAINST DIABETIC NEPHROPATHY IN MICE
Herzog W.	-	LATE BREAKING CLINICAL TRIAL: BIVALIRUDIN WITH AND WITHOUT EPTIFIBATIDE FOR ELECTIVE STENTING: A PHARMACODYNAMIC STUDY OF PLATELET REACTIVITY IN RELATION TO THE OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION (THE CLEAR PLATELETS-2 STUDY)
Herzog S.	-	THE THROMBOMODULIN PROTEIN C SYSTEM PROTECTS AGAINST DIABETIC NEUROPATHY VIA TWO INDEPENDENT MECHANISMS
Hess J.R.	-	CHANGES IN THROMBIN GENERATION KINETICS FOLLOWING HEMORRHAGIC SHOCK AND RESUSCITATION IN PIGS
Hesslein A.	-	REMOVAL OF PORCINE PARVOVIRUS SPIKED INTO SAMPLES OF HUMAN RECOMBINANT FACTOR VIII
Hettiarachchi R.	-	DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT
Heward J.	-	BCL-2 AND BCL-XL EXPRESSION IN HUMAN CHOLANGIOCARCINOMA CELLS
Hewitt J.	-	MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
	-	HOMOZYGOUS FACTOR V DEFICIENCY WITH MILD CLINICAL PHENOTYPE
Heylen E.	-	GENERATION OF CARBOXYPEPTIDASE U (TAFIA) IN ISCHEMIC STROKE PATIENTS RECEIVING THROMBOLYTIC THERAPY
	-	PROCARBOXYPEPTIDASE U (TAFI) PLASMA LEVELS IN PATIENTS WITH HEREDITARY THROMBOPHILIA
	-	THE ZYMOGEN PROCARBOXYPEPTIDASE U (TAFI) DOES NOT INFLUENCE THE FIBRINOLYTIC RATE
Hickey M.J.	-	IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Hickey K.P.	-	EVALUATION OF A NEW LATEX-BASED HOMOCYSTEINE ASSAY
	-	SENSITIVITY OF THE HEMOSIL THROMBOPATH ASSAY TO DEFECTS IN THE PROTEIN C ANTICOAGULANT PATHWAY
Hicks M.	-	QUALITY OF ANTICOAGULATION MANAGEMENT IN PRIMARY CARE PRACTICE
Hidaka Y.	-	IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
	-	IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
Hiddink L.	-	ANTIPHOSPHOLIPID ANTIBODIES DISTURB 2D LATTICE FORMATION OF ANNEXINE A5 ON ACTIVATED PLATELETS
Hiden M.	-	THROMBIN GENERATION IN OBESE CHILDREN AFTER WEIGHT REDUCTION
	-	THROMBIN GENERATION IN NORMAL UNCOMPLICATED PREGNANCY
Hiebert L.M.	-	ORALLY ADMINISTERED HEPARIN HAS CUMULATIVE ANTITHROMBOTIC EFFECTS WHEN ADMINISTERED IN REPEATED DOSES
Higaki N.	-	INCIDENCE OF PULMONARY THROMBOEMBOLISM IN AUTOPSY CASES IN A JAPANESE GENERAL HOSPITAL
Higashi T.	-	GTP-INDUCED DENSE GRANULE SECRETION IN PLATELETS IS MEDIATED BY RAL-EXOCYST PATHWAY
Higashihara M.	-	LOCALIZATION AND EXPRESSION OF MYOSIN VI IN HUMAN HAEMATOPOIETIC CELLS INCLUDING PLATELETS
High K.A.	-	PROGRESS AND HURDLES IN NOVEL GENETIC THERAPIES FOR HEMOPHILIA
Hilbert L.	-	IDENTIFICATION AND EXPRESSION OF R763G MUTATION ABOLISHING THE CLEAVAGE OF VON WILLEBRAND FACTOR PROPEPTIDE, AT THE HETEROZYGOUS AND HOMOZYGOUS STATE
Hilden I.	-	FACTOR VIII A2 DOMAIN INTERACTION WITH LRP: IN VITRO AND IN VIVO ANALYSES
Hilfinger J.	-	THROMBOSTATIN FM19 - A THROMBIN RECEPTOR ACTIVATION ANTAGONIST
Hill F.	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Hill M.	-	POTENTIAL ROLE OF RAPID MOLECULAR SCREENING OF PATIENTS WITH DYSFIBRINOGENEMIA
Hill F.G.H.	-	A NOVEL CANDIDATE A/T789P MUTATION IDENTIFIED IN FIVE PATIENTS WITH TYPE 2N VON WILLEBRAND DISEASE FROM TWO DIFFERENT FAMILIES
Hill M.	-	THE UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME (UK NEQAS) FOR MOLECULAR GENETIC TESTING IN HAEMOPHILIA
	-	WARFARIN PHARMACOGENOMICS: A MULTIPLEX METHOD FOR CYP2C9 AND VKORC1 GENOTYPING
	-	GENETIC ANALYSIS IN HYPOFIBRINOGENEMIA IN ELEVEN FAMILIES
Hill F.	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
Hill S.N.	-	GPIIB-IIIA ANTAGONISTS HAVE A SIGNIFICANT EFFECT ON THROMBUS STABILITY BY DISPLACING BOUND FIBRINOGEN
Hill F.G.H.	-	A MUTATION IN EXON 27 OF THE VWF GENE CAUSING TYPE 2M AND TYPE 3 VON WILLEBRAND DISEASE IN THREE PATIENTS IN A FAMILY FROM THE WEST OF SCOTLAND
Hill F.	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
Hill F.G.H.	-	HETEROGENEOUS SEQUENCE CHANGES IN THE PROMOTER AND CODING SEQUENCE OF THE FACTOR VIII GENE IDENTIFIED IN 247 FAMILIES FROM THE UK
Hillarp A.	-	ANTI-PROTEIN S ANTIBODIES IN CHILDREN WITH PURPURA FULMINANS AND IN HEALTHY CHILDREN FOLLOWING VARICELLA AS WELL AS IN CHILDREN WITH THROMBOSIS
Hilliard E.	-	LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Hillis G.	-	PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIC EVENTS IN PATIENTS UNDERGOING MAJOR VASCULAR SURGERY
Hillmayer K.	-	THE BIOCHEMICAL IMPORTANCE OF GLYCOSYLATION IN THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR
Hiltunen L.M.	-	BLOOD GROUP AB AND FV LEIDEN AS RISK FACTORS FOR PRE-ECLAMPSIA
Hindorff L.A.	-	ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
Hirabayashi A.	-	BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF KDN-7438, A NOVEL SYNTHETIC TISSUE FACTOR/FACTOR VIIA INHIBITOR
Hirbawi J.	-	THE ROLE OF THE ACIDIC COOH-TERMINAL REGION OF FACTOR VA HEAVY CHAIN DURING ACTIVATION OF PROTHROMBIN BY PROTHROMBINASE
Hirmerova J.	-	RISK FACTORS OF INCOMPLETE RECANALISATION AFTER DEEP VEIN THROMBOSIS
Hirosawa S.	-	INTRACELLULAR DEGRADATION OF NATURALLY OCCURRING PROTEIN C (PC) MUTANTS
	-	1,25(OH)2D3 BLOCKS TNF-INDUCED MONOCYTIC TISSUE FACTOR EXPRESSION BY INHIBITION OF TRANSCRIPTION FACTORS AP-1 AND NF-KAPPAB
Hirose J.	-	IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Hirota-Kawadobora M.	-	MARKEDLY IMPAIRED BUT SIGNIFICANT THROMBIN-CATALYZED FIBRIN POLYMERIZATION OBSERVED AT VARIANT FIBRINOGENS AT GAMMA364ASP RESIDUE IS ARISEN FROM B-KNOB AND B-HOLE BONDING
Hiroto Y.	-	PHYTOESTROGENS DOWN-REGULATE PROTEIN S EXPRESSION IN HEPG2 CELLS
Hirsch S.	-	TRENDS IN FVIII AND FIX USE IN THE UNITED KINGDOM 2001-2006
Hirschl M.	-	EXCESS BODY FAT AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM
	-	6 MONTHS VERSUS PROLONGED ANTICOAGULATION FOR PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH HIGH FACTOR VIII LEVELS
Hirsh J.	-	COMBINED ANTIPLATELET AND ANTICOAGULANT THERAPY: CLINICAL BENEFITS AND RISKS
	-	ASSOCIATION BETWEEN ASYMPTOMATIC DEEP-VEIN THROMBOSIS DETECTED BY SCREENING VENOGRAPHY AND SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING ELECTIVE HIP OR KNEE SURGERY A SYSTEMATIC REVIEW
	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX REDUCES BRAIN EMBOLI DURING HYPOTHERMIC CARDIOPULMONARY BYPASS IN PIGS
Hishinuma I.	-	EFFECTS OF E5555, A PROTEASE-ACTIVATED RECEPTOR-1 ANTAGONIST, ON THE INFLAMMATORY MARKERS IN VITRO
Hitos K.	-	VENOUS THROMBOEMBOLISM AND GYNAECOLOGICAL ONCOLOGY SURGERY
	-	BLEEDING COMPLICATIONS ASSOCIATED WITH PHARMACOLOGICAL PROPHYLAXIS FOR MAJOR ORTHOPAEDIC SURGERY
	-	PRACTICE PATTERNS IN PREVENTION OF VENOUS THROMBOEMBOLISM IN PRIMARY TOTAL HIP ARTHROPLASTY PATIENTS
	-	VENOUS THROMBOEMBOLISM PROPHYLAXIS IN CRITICALLY-ILL SURGICAL PATIENTS
Hiura H.	-	IMMUNO-PURIFICATION OF PLASMA ADAMTS13 AND ITS PHYSICO-CHEMICAL CHARACTERIZATION
Hjemdahl P.	-	EFFECT OF CLOPIDOGREL TREATMENT ON STRESS-INDUCED PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIA IN ASPIRIN-TREATED PATIENTS WITH STABLE CORONARY ARTERY DISEASE
	-	PLATELETS AND SUBENDOTHELIAL MATRIX PROTEINS DIFFERENTIALLY SUPPORT ADHESION OF LYMPHOCYTE SUBPOPULATIONS UNDER ARTERIAL SHEAR STRESS
	-	INCREASED PLATELET PROCOAGULANT ACTIVITY IN TYPE 2 DIABETIC PATIENTS: INHIBITION BY GPIIB/IIIA BLOCKADE
	-	NO EFFECT OF LIPID LOWERING BY SIMVASTATIN OR SIMVASTATIN AND EZETIMIBE ON PLATELET FUNCTION IN PATIENTS WITH TYPE 2 DIABETES OR IMPAIRED GLUCOSE TOLERANCE AND CORONARY ARTERY DISEASE
Hladíková M.	-	USE THROMBIN GENERATION ASSAY AND THROMBELASTOGRAPHY IN MONITORING OF RESPONSE TO DDAVP IN PATIENTS WITH TYPE 1 AND 2A VON WILLEBRAND DISEASE
Hlusi A.	-	THROMBIN GENERATION TEST AN EXPERIENCE OF ONE CENTRE IN THROMBOPHILIA PATIENTS
Ho P.L.	-	FCGAMMARII MEDIATES PLATELET AGGREGATION CAUSED BY DISINTEGRINS AND GPIIB/IIIA MONOCLONAL ANTIBODY, AP2
Ho V.	-	USE OF THROMBOELASTOGRAPHY TO DEFINE THE ROLE(S) OF NEUTROPHIL ELASTASE DURING NORMAL HAEMOSTASIS IN VITRO
Ho M.	-	HOMOZYGOUS FACTOR V DEFICIENCY WITH MILD CLINICAL PHENOTYPE
Höbert E.	-	HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
Hockings P.D.	-	THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 REDUCES THROMBUS FORMATION IN A RAT MODEL
Hod H.	-	RESPONSIVENESS TO CLOPIDOGREL AND ASPIRIN AMONG PATIENTS WITH ACUTE CORONARY SYNDROME AS ASSESSED BY THE IMPACT-R [CONE AND PLATE(LET) ANALYZER]
	-	CLOPIDOGREL UNRESPONSIVENESS OVERCOME BY RELOADING: ASSESSEMENT BY PLATELET AGGREGOMETRY AND IMPACT-R [CONE AND PLATE(LET) ANALYZER]
Höehr N.F.	-	EVALUATION OF MILD HHCY IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN APOE-DEFICIENT AND NORMAL MICE
Hoekstra T.	-	ALCOHOL CONSUMPTION IS NOT ASSOCIATED WITH FIBRINOGEN IN A LARGE POPULATION OF AFRICAN BLACKS
Hoelschermann H.	-	THE DISTRIBUTION OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP) IN CAROTID AND CORONARY ATHEROSCLEROTIC PLAQUES IN SUBJECTS GENOTYPED FOR THE MARBURG I POLYMORPHISM
Hoes A.W.	-	A DIAGNOSTIC TOOL TO SAFELY EXCLUDE DVT IN HIGH RISK GROUPS
	-	A DIAGNOSTIC TOOL TO SAFELY EXCLUDE DVT IN PRIMARY CARE: A VALIDATION STUDY
Hofbeck M.	-	ASPIRIN-RESISTANCE IN CHILDREN
Hofer R.	-	THROMBIN GENERATION IN NORMAL UNCOMPLICATED PREGNANCY
Hoffer L.	-	PRION PROTEIN (PRPSC) REMOVAL BY CHROMATOGRAPHY PURIFICATION AND NANOFILTRATION OF FIXS AND PCC
Hoffman R.G.	-	THE EFFECT OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR PROPEPTIDE LEVELS IN NORMAL INDIVIDUALS
Hoffman M.	-	LOW INTENSITY LASER THERAPY SPEEDS WOUND HEALING IN HEMOPHILIA B MICE
	-	TISSUE FACTOR AROUND DERMAL VESSELS HAS BOUND FACTOR VII IN THE ABSENCE OF INJURY
	-	RESTORING INITIAL THROMBIN GENERATION DOES NOT NORMALIZE CUTANEOUS WOUND HEALING IN HEMOPHILIA B
	-	HIGH DOSE FACTOR VIIA CORRECTS THROMBIN GENERATION IN A MODEL OF DILUTIONAL COAGULOPATHY
Hoffmann U.	-	HEAT SHOCK PROTEIN 70 (HSP 70) LEVELS AS PROGNOSTIC MARKER OF SEPTIC PATIENTS
Hoffmanns P.	-	INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) IN NON-SURGICAL PATIENTS AT HOSPITAL ADMISSION
Hoffmanns W.	-	INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) IN NON-SURGICAL PATIENTS AT HOSPITAL ADMISSION
Hofmaier S.	-	IN VIVO ASSESSMENT OF EXPERIMENTAL MELANOMA METASTASIS BY INTRAVITAL MICROSCOPY REVEALS A CRITICAL ROLE OF PLATELETS AND GLYCOPROTEIN IIB
Hofman-Bang C.	-	EFFECT OF CLOPIDOGREL TREATMENT ON STRESS-INDUCED PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIA IN ASPIRIN-TREATED PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Hofmann M.	-	PROTEIN C- CONCENTRATE BY SEPSIS WITH PURPURA FULMINANS
Hofmann K.	-	PROTEIN C- CONCENTRATE BY SEPSIS WITH PURPURA FULMINANS
Hofstede F.F.G.	-	OVERWEIGHT IN DUTCH HAEMOPHILIA PATIENTS
Hogarth M.	-	IMPROVING PATIENT SAFETY WHEN STARTING WARFARIN IN THE HOSPITAL: THE WARFDOCS STUDY
Hogarth M.P.	-	IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Hogenboom S.	-	COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION
Hogg P.J.	-	PLATELET ACTIVATION TRIGGERS ACTIVATION OF THE TISSUE FACTOR REGULATOR, PROTEIN DISULPHIDE ISOMERASE
Hogwood J.	-	NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
	-	CORN TRYPSIN INHIBITOR AND THE CONTACT FACTOR PATHWAY IN THE THROMBIN GENERATION TEST (TGT)
	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
	-	OLIGOSACCHARIDES FROM DIFFERENT LOW MOLECULAR WEIGHT HEPARINS HAVE DIFFERENT ANTICOAGULANT AND PROTAMINE SULPHATE NEUTRALIZATION PROFILES
	-	COMPARISON OF FIX CONCENTRATES BY CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY (CAT)
Hoibraaten E.	-	TISSUE FACTOR PATHWAY INHIBITOR (TFPI) POLYMORPHISMS, HORMONE REPLACEMENT THERAPY (HRT) AND RISK OF VENOUS THROMBOEMBOLISM (VTE)
Holcomb J.B.	-	CHANGES IN THROMBIN GENERATION KINETICS FOLLOWING HEMORRHAGIC SHOCK AND RESUSCITATION IN PIGS
Holcroft C.	-	ELEVATED PLASMA GAS6 LEVELS ARE ASSOCIATED WITH CLOT BURDEN AND UNDERLYING MALIGNANCY IN DEEP-VEIN THROMBOSIS
Holder R.	-	BAYESIAN STATISTICAL MODELLING OF PATIENTS INR RECORDS USING REPEATED MEASURES MODELS AND INDIVIDUAL TIME SERIES
Holewijn S.	-	ELEVATED MARKERS OF INFLAMMATION IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS ARE A RISK FACTOR FOR ELEVATED VENOUS RESISTANCE AS A PROXY OF THE POST-THROMBOTIC SYNDROME
Holikova M.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Hollamby S.	-	MAJOR OBSTETRIC HAEMORRGHAGE IN LATE TERMINATION OF PREGNANCY
	-	MAJOR OBSTETRIC HAEMORRHAGE IN LATE TERMINATION OF PREGNANCY
Holland C.M.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Hollande E.	-	DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH
Hollenbach S.	-	PRT060128, A NOVEL, DIRECT-ACTING ORALLY AVAILABLE P2Y12 ANTAGONIST, CONFERS SUPERIOR ANTITHROMBOTIC ACTIVITY OVER CLOPIDOGREL IN A MOUSE THROMBOSIS MODEL
Hollingsworth R.	-	TRENDS IN FVIII AND FIX USE IN THE UNITED KINGDOM 2001-2006
Hollon W.	-	TISSUE PLASMINOGEN ACTIVATOR (RTPA) INDUCED FIBRINOLYSIS - STANDARDIZATION OF METHOD ON THROMBELASTOGRAPHY
	-	FIBRINOLYTIC PARAMETERS IN CHILDREN WITH NON-CATHETER RELATED DEEP VENOUS THROMBOSIS
	-	INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
Holly P.	-	ACQUIRED HAEMOPHILIA A WITH INHIBITOR - CASE REPORT
Holm P.K.	-	FACTOR VIII A2 DOMAIN INTERACTION WITH LRP: IN VITRO AND IN VIVO ANALYSES
	-	DEVELOPMENT OF LONG-ACTING FVIIA DERIVATIVES BY GLYCOPEGYLATION
Holmberg L.	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
Holmberg H.L.	-	NN1731, A RFVIIA ANALOGUE, SHOWS HIGH EFFICACY AND FAST ONSET OF ACTION IN A SEVERE TAIL BLEEDING MODEL IN HAEMOPHILIA A MICE
Holmberg L.	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Holmberg A.	-	DALTEPARIN SHORTENS HUMAN LABOR
Holme P.A.	-	HUMAN PLATELETS AND MEGAKARYOCYTES CONTAIN FACTOR X mRNA, DETECTED WITH REAL-TIME QUANTITATIVE RT-PCR
	-	ACTIVATED COAGULATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Holmes M.	-	CHEMOANTICOAGULATION VERSUS CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): RESULTS OF THE INTERIM ANALYSIS OF THE FRAGEM TRIAL
Holmström M.	-	THE EXPRESSION OF PLATELET RECEPTORS AND MARKERS OF PLATELET ACTIVATION IN PATIENTS WITH HEMOPHILIA A AND VON WILLEBRANDS DISEASE
Holzinger T.	-	HEAT SHOCK PROTEIN 70 (HSP 70) LEVELS AS PROGNOSTIC MARKER OF SEPTIC PATIENTS
Homann J.	-	HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
Homburg C.H.	-	JAK2-V617F IS A RISK FACTOR FOR VENOUS THROMBOEMBOLISM
Homer-Vanniasinkam S.	-	NITRIC OXIDE INHIBITS ADHESION TO COLLAGEN BY MODULATING SENSITIVITY TO PLATELET DERIVED SECONDARY AGONISTS
Homma T.	-	BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF KDN-7438, A NOVEL SYNTHETIC TISSUE FACTOR/FACTOR VIIA INHIBITOR
Hommais A.	-	EXPRESSION AND CHARACTERISATION OF 4 ADAMTS13 MUTATIONS IDENTIFIED IN PATIENTS WITH TTP (UPSHAW-SCHULMAN SYNDROME)
Honda M.	-	IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Honda S.	-	SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS
	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
Honda Y.	-	EFFECT OF A FACTOR XA INHIBITOR DU-176B ON INTRACEREBRAL HEMORRHAGE IN RATS: A WIDER SAFETY MARGIN COMPARED WITH A THROMBIN INHIBITOR
	-	ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE, RECOMBINANT FACTOR VIII AND FACTOR IX REVERSE PROLONGED CLOTTING TIME INDUCED BY DU-176B, A DIRECT FACTOR XA INHIBITOR, IN HUMAN PLASMA
Hondares M.C.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Hong Y.	-	THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Hong S.	-	C936T MUTATION IN THE VEGF GENE AS AN INDEPENDENT RISK FACTOR FOR PATIENTS WITH SILENT BRAIN INFARCTION
	-	THE INHIBITORY ACTIVITY AND MECHANISM OF BUD-030, A NOVEL INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS
	-	POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
	-	BIOCHEMICAL ANALYSIS OF RECOMBINANT FIBRINOGEN AALPHAGLN328PRO; PREVIOUSLY REPORTED AS FIBRINOGEN VARIANT SEOUL II WITH IMPAIRED FIBRIN ALPHA-CHAIN CROSS-LINKING
Hong J.	-	OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
Hong S.	-	GENDER-SPECIFIC ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS (VEGF -2578CA AND -634GC) AND THE RISK OF ISCHEMIC STROKE
Hong J.	-	EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
Hongeng S.	-	NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION
	-	THE USE OF RITUXIMAB AS AN ADJUVANT THERAPY TO INDUCE IMMUNE TOLERANCE IN CHILDREN WITH HEMOPHILIA A AND B
Honnart D.	-	PULMONARY EMBOLISM DIAGNOSTIC TOOLS IN FRENCH EMERGENCY DEPARTMENTS: AVAILABILITY INCREASES BUT PHYSICIAN KNOWLEDGE REMAINS POOR
Hooley E.	-	MOLECULAR MODEL OF THE PREKALLEKREIN STRUCTURE
Hooper W.C.	-	U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Hooper C.	-	THE ALPHA FIBRINOGEN THR312ALA POLYMORPHISM AND VENOUS THROMBOEMBOLISM IN AMERICAN CAUCASIANS AND AFRICAN AMERICANS: THE GATE STUDY
Hooper W.	-	POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION
	-	MAJOR BLEEDING IN ACUTE CORONARY SYNDROME PATIENTS IS ASSOCIATED WITH A MAKED PRO-INFLAMMATORY RESPONSE: RESULTS FROM THE ACUITY INFLAMMATORY BIOMARKER SUB-STUDY
Hooper C.	-	PULMONARY EMBOLISM, OBESITY, DIABETES, AND HYPERTENSION AMONG AMERICAN CAUCASIANS IN THE GATE STUDY
	-	VENOUS THROMBOEMBOLISM, FACTOR V LEIDEN, AND PROTHROMBIN 20210 AMONG AMERICAN CAUCASIANS IN THE GATE STUDY
Hoorfar H.	-	HELICOBACTER PYLORI ERADICATION CAN INDUCE PLATELET RECOVERY IN CHRONIC REFRACTORY IDIOPATHIC THROMBOCYTOPENIC PURPURA
	-	RARE COAGULATION DISORDERS IN ISFAHAN HEMOPHILIA CENTER
Hoots K.W.	-	THE USE OF FEIBA DURING SURGERIES IN HAEMOPHILIA PATIENTS WITH INHIBITORS TO FACTOR VIII AND IX
Hoots W.	-	SENSITIVITY TO ACTIVATED PROTEIN C (APC) IS INCREASED DURING THE SECRETORY PHASE OF THE MENSTRUAL CYCLE
	-	FAILURE OF IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA B PATIENTS WITH C, T 6460 NONSENSE MUTATION
	-	ASSOCIATION BETWEEN A HISTORY OF INHIBITORS AND DELAYS IN SKELETAL MATURATION IN ADOLESCENTS WITH HEMOPHILIA
Hop W.C.J.	-	AGE-RELATED CHANGES BY ASPARAGINASE ON COAGULATION AND FIBRINOLYSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Hopman W.	-	THE PREVALENCE OF SYMPTOMATIC VON WILLEBRAND DISEASE (VWD) IN PRIMARY CARE PRACTICE
Hoppensteadt D.	-	PREVALENCE OF CROSS-REACTIVE EPITOPES TO BOVINE FACTOR VA LIGHT CHAIN FRAGMENTS IN NORMALS AND END STAGE RENAL DISEASE PATEINTS
	-	PROTEINOMIC PROFILING OF TISSUE FACTOR MEDIATED PROTHROMBIN ACTIVATION PRODUCTS AND THEIR INHIBITION BY DIRECT ANTITHROMBIN AND ANTI-XA AGENTS
	-	UPREGULATION OF MYELOPEROXIDASE IN END STAGE RENAL DISEASE AND ITS MODULATION BY HEMODIALYSIS
	-	FIBRINOLYTIC DEFICIT CONTRIBUTES TO THE THROMBOTIC COMPLICATIONS IN END STAGE RENAL DISEASE. PROFILING OF PLASMINOGEN ACTIVATOR INHIBITOR, TISSUE PLASMINOGEN ACTIVATOR, FACTOR XIII THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR, AND ALPHA2 ANTIPLASMIN
	-	ARGATROBAN IS CAPABLE OF PASSING THROUGH THE BLOOD BRAIN BARRIER. POTENTIAL IMPLICATIONS IN THE MANAGEMENT OF THROMBOTIC STROKE
	-	GLYCOPROTEIN IIB/IIIA RECEPTOR DENSITY MEASUREMENT. IMPLICATIONS IN THE MONITORING OF ANTIPLATELET DRUGS
	-	UPREGULATION OF NITRIC OXIDE AND ASYMMETRIC DIMETHYLARGININE LEVELS IN MALIGNANCY ASSOCIATED THROMBOSIS AND THEIR MODULATION BY ANTICOAGULANTS
	-	COMPARATIVE STUDY ON THE ANTICOAGULANT EFFECTS OF UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS, LOWER LOW MOLECULAR WEIGHT HEPARINS AND PENTASACCAHRIDE AS MEASURED BY WHOLE BLOOD ACT, ANTI-XA AND A NEWLY DEVELOPED PROTHROMBINASE INDUCED CLOTTING TIME
	-	UPREGULATION OF SURROGATE MARKERS OF INFLAMMATION AND THROMBOGENESIS IN ESRD PATIENTS, PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS
	-	EFFECT OF ANTIDEPRESSANT DRUG TREATMENT ON INFLAMMATORY AND PLATELET ACTIVATION BIOMARKERS IN DEPRESSION
	-	DIFFERENTIAL EFFECTS OF FXA INHIBITORS AND HEPARINS IN SIMULATED ARTERIAL AND VENOUS THROMBOSIS
	-	ANTIINFLAMMATORY EFFECTS OF ARGATROBAN CAN BE DIFFERENTIATED FROM OTHER DIRECT THROMBIN INHIBITORS. EXPERIMENTAL AND CLINICAL OBSERVATIONS
	-	POTENTIAL ROLE OF ADAMTS13/FXI COMPLEXES IN THE PATHOGENESIS OF ESRD
	-	UPREGULATION OF INFLAMMATORY MEDIATORS IN LUNG CANCER AND THEIR MODULATION BY ORAL ANTICOAGULANT THERAPY
	-	FACTOR V REMOVAL FROM BOVINE THROMBIN USED AS A TOPICAL HEMOSTAT IN SURGERY: IMPROVED PURITY THROUGH A NEW MANUFACTURING PROCESS
	-	BETAINE (TRIMETHYLGLYCINE), A NOVEL ORAL ANTICOAGULANT WITH COMBINED NITRIC OXIDE AND TISSUE FACTOR PATHWAY INHIBITOR RELEASE POTENTIAL. IMPLICATIONS IN THE MANAGEMENT OF VASCULAR DISEASES
	-	DIFFERENTIATION OF LOW MOLECULAR WEIGHT HEPARINS AS STUDIED BY MOLECULAR WEIGHT PROFILE AND HEPARINASE-I DEPOLYMERIZATION: PHARMACOLOGIC IMPLICATIONS
	-	ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE
	-	RECOMBINANT THROMBOMODULIN DOES NOT CROSS REACT WITH ANTI-HEPARIN PLATELET FACTOR 4 ANTIBODIES. POTENTIAL IMPLICATION FOR ANTICOAGULATION OF HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS
	-	TRYPSIN MEDIATED ACTIVATION OF THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR (CARBOXYPEPTIDASE U)
	-	UPREGULATION OF MICROPARTICLES IN HEPARIN INDUCED THROMBOCYTOPENIA (HIT) AND IT'S MODULATION BY ARGATROBAN
	-	PREGNANCY ASSOCIATED ALTERATIONS OF THE INFLAMMATORY MEDIATORS, TISSUE FACTOR PATHWAY INHIBITOR AND PROTEIN Z
	-	POTENTIAL OF THE FACTOR XA INHIBITOR RIVAROXABAN FOR THE ANTICOAGULATION MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
	-	NITRIC OXIDE LEVELS ARE INCREASED FOLLOWING BRACHYTHERAPY COMPARED TO STENTING. IMPLICATIONS IN CORONARY RESTENOTIC COMPLICATIONS
	-	HEMODIALYSIS DOWN REGULATES THE INFLAMMATORY MEDIATORS IN PATIENTS WITH END STAGE RENAL DISEASE
	-	RELATIVE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARINS IN HUMAN AND FELINE BLOOD PLASMA. POTENTIAL THERAPEUTIC IMPLICATIONS
	-	THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL
	-	DEFIBROTIDE MEDIATED INHIBITION OF HEPARINASE I. POTENTIAL CLINICAL IMPLICATIONS
	-	THE PHARMACOKINETICS OF DEFIBROTIDE IN NON-HUMAN PRIMATES IS DOSE DEPENDENT
	-	DIFFERENCES IN THE OLIGOSACCHARIDE COMPOSITION OF GENERIC VERSIONS OF ENOXAPARIN AND DALTEPARIN
	-	DEFIBROTIDE AND ITS MOLECULAR FRACTIONS DO NOT CROSS-REACT WITH HIT ANTIBODIES. IMPLICATIONS IN THE MANAGEMENT OF HIT
	-	DOWN REGULATION OF THROMBOTIC AND INFLAMMATORY MEDIATORS IN PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH CLOPIDOGREL. RELEVANCE TO THE OBSERVED CLINICAL EFFECTS
Horak J.	-	DECREASE OF SOLUBLE P-SELECTIN AND INHIBITION BOTH, ACTIVATED FACTOR XA AND THROMBIN AFTER I.V.ENOXAPARIN DURING PCI
Horellou M.	-	IMPACT OF RISK FACTORS ASSOCIATED WITH VENOUS THROMBOSIS IN CYPROTERONE ACETATE AND ETHYNIL-ESTRADIOL USERS OR OTHER ORAL CONTRACEPTIVES USERS AND POSSIBLY PREVENTABLE CASES
Horellou M.H.	-	SOURCE OF TISSUE FACTOR LEADING TO DISCREPANT PLASMA FVII LEVELS IN EIGHT FVII-DEFICIENT PATIENTS OF AFRICAN ORIGIN
Horellou M.	-	SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
	-	D-DIMER MEASUREMENT AND THROMBOPHILIA SCREENING IN THE FOLLOW-UP OF PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM
Horie S.	-	CIRCADIAN VARIATIONS IN COAGULATION AND FIBRINOLYTIC FACTORS AMONG FOUR STRAINS OF MICE
	-	THROMBOMODULIN REGULATES GENE EXPRESSION OF ADHESION MOLECULES ON THE SURFACE OF ENDOTHELIAL CELLS EXPOSED TO HT1080 FIBROSARCOMA CELLS
Horio T.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Horita T.	-	THE P38 MITOGEN-ACTIVATE PROTEIN KINASE MAPK) PATHWAY MEDIATES THE INDUCTION OF TISSUE FACTOR EXPRESSION BY PHOSPHATIDYLSERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODIES WITH LUPUS ANTICOAGULANT ACTIVITY
Horita D.A.	-	DIFFERENT INTEGRINS, DIFFERENT STATES, DIFFERENT SHAPES?
Horita T.	-	DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME
Horita D.A.	-	DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
Horiuchi H.	-	GTP-INDUCED DENSE GRANULE SECRETION IN PLATELETS IS MEDIATED BY RAL-EXOCYST PATHWAY
	-	ASPIRIN EFFICACY: ANALYSIS OF WHOLE BLOOD-AGGREGATION USING THE SCREEN FILTRATION PRESSURE METHOD
Horlé B.	-	SERIOUS BLEEDS IN HAEMOPHILIAC A CHILDREN AND CONTINUOUS INFUSION (CI)
Horter S.	-	AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
Horton S.	-	MEASURES OF THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS (CPB) IN
Horvat I.	-	ACL TOP PERFORMANCE IN ROUTINE COAGULATION TESTING
Horvath A.	-	CHARACTERISATION OF RZPI PRODUCED IN ESCHERICHIA COLI
Horvath C.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Horvath A.	-	DESMOTEPLASE-MEDIATED PLASMINOGEN ACTIVATION AND CLOT LYSIS ARE ANTAGONIZED BY THE LYSINE ANALOGUE TRANEXAMIC ACID
Horvathova D.	-	BLEEDING AND THROMBOTIC MANIFESTATION IN 58 PATIENTS WITH CONGENITAL DYSFIBRINOGENEMIA
	-	FACTOR VIIII INHIBITOR IN SEVERE HEMOPHILIA A TREATED WITH PD-FVIII CONCENTRATES
	-	TORPID CLINICAL COURSE OF THROMBOTIC THROMBOCYTOPENIC PURPURA
Horvath-Puho E.	-	VENOUS THROMBOEMBOLISM AND SUBSEQUENT HOSPITALIZATION DUE TO ACUTE CARDIOVASCULAR EVENTS. A 20 YEARS FOLLOW-UP STUDY
Hosak L.	-	ASSOCIATION OF VENOUS THROMBOEMBOLISM AND OLANZAPINE
Hosaka Y.	-	IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Hoshi A.	-	1,25(OH)2D3 BLOCKS TNF-INDUCED MONOCYTIC TISSUE FACTOR EXPRESSION BY INHIBITION OF TRANSCRIPTION FACTORS AP-1 AND NF-KAPPAB
Hoshiko S.	-	A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS
Hossain N.	-	USE OF RECOMBINANT ACTIVETED FACTOR VII FOR THE CONTROL OF POST PARTUM HEMORRHAGE: A CASE SERIES
Hosur S.	-	A CASE OF NORMAL PLATELET COUNT HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
Hotchkiss K.A.	-	PLATELET ACTIVATION TRIGGERS ACTIVATION OF THE TISSUE FACTOR REGULATOR, PROTEIN DISULPHIDE ISOMERASE
Ho-Tin-Noe B.	-	CORTICAL NEURONS AGGREGATE IN RESPONSE TO PLASMIN FORMED AT THEIR SURFACE BY TPA
Hou M.	-	CORRECTION OF TH1 DOMINANT CYTOKINE PROFILES BY HIGH DOSE DEXAMETHASONE IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
	-	PHENOTYPE AND FUNCTION OF CD4+CD25+ REGULATORY T CELLS IN MOUSE MODEL OF EXPERIMENTAL TRANSIENT IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH INDIRUBIN
	-	IDENTIFICATION OF ANERGY-RELATED GENES IN IDIOPATHIC THROMBOCYTOPENIC PURPURA USING MICROARRAY ANALYSIS
	-	THE SCREENING ASSAY OF PLATELET- ASSOCIATED IMMUNOGLOBULIN G CAN NOT IMPROVE THE SENSITIVITY OF MONOCLONAL ANTIBODY IMMOBILIZATION OF PLATELET ANTIGENS ASSAY IN IMMUNE THROMBOCYTOPENIC PURPURA
	-	THE CONSTRUCTION OF A HUMANIZED PHAGE ANTIBODY LIBRARY OF ANTI-PLATELET GPIIB/IIIA SINGLE CHAIN FV
Houdard E.	-	CYP2C19*2 POLYMORPHISM INFLUENCES PLATELET FUNCTIONNALITY IN RESPONSE TO CLOPIDROGEL TREATMENT
Hough C.A.	-	INFLUENCE OF A GT REPEAT ELEMENT ON SHEAR STRESS-RESPONSIVENESS OF THE VWF GENE PROMOTER
Hough C.	-	IMMUNOGLOBULIN ISOTYPES AND FUNCTIONAL ANTI-FVIII ANTIBODIES IN RESPONSE TO FVIII TREATMENT IN TWO STRAINS OF HEMOPHILIA A MICE
	-	IMMUNE TOLERANCE INDUCTION TO FVIII IN HEMOPHILIA A MICE USING SUBCUTANEOUSLY IMPLANTED FVIII GENE-MODIFIED ENDOTHELIAL PROGENITOR CELLS
	-	ENHANCED TOLEROGENIC PRESENTATION OF FVIII BY ANDROGRAPHOLIDE-TREATED IMMATURE DENDRITIC CELLS
	-	SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
	-	THE SPLENIC MICRO-ENVIRONMENT AND FVIII-VWF INTERACTION ARE DETERMINANTS OF THE IMMUNOGENIC PRESENTATION OF FVIII BY DENDRITIC CELLS
	-	ANTI-CD3 IN COMBINATION WITH NASAL FVIII-A2 DOMAIN DECREASES FVIII INHIBITORS
Houllier A.	-	EXPRESSION AND CHARACTERISATION OF 4 ADAMTS13 MUTATIONS IDENTIFIED IN PATIENTS WITH TTP (UPSHAW-SCHULMAN SYNDROME)
Houmen H.	-	THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Housman D.E.	-	CALDAG-GEFI-DEFICIENCY CAUSES IMPAIRED BETA1, BETA2, AND BETA3 INTEGRIN ACTIVATION IN NEUTROPHILS AND PLATELETS: A MODEL FOR LEUKOCYTE ADHESION DEFICIENCY-III (LAD-III)
Houwing-Duistermaat J.J.	-	SELECTIN HAPLOTYPES AND THE RISK OF VENOUS THROMBOSIS; INFLUENCE OF LINKAGE DISEQUILIBRIUM WITH THE FACTOR V LEIDEN MUTATION
Hovens M.M.C.	-	HIGH D-DIMER LEVEL INCREASES THE LIKELIHOOD OF PULMONARY EMBOLISM IN A HIGH-RISK POPULATION
	-	CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS
	-	HIGH LEVELS OF LDL-CHOLESTEROL AND TRIGLYCERIDES AND SUBOPTIMAL GLYCEMIC CONTROL PREDICT DIMINISHED EX VIVO ASPIRIN RESPONSIVENESS IN PATIENTS WITH TYPE 2 DIABETES
	-	LABORATORY-DEFINED ASPIRIN RESISTANCE IS ASSOCIATED WITH A HIGHER RISK OF RECURRENT CARDIOVASCULAR EVENTS: A META-ANALYSIS
Hovsepian L.	-	FUNCTIONAL VARIABILITY OF PLATELET RESPONSE TO CLOPIDOGREL CORRELATES WITH P2Y12 RECEPTOR OCCUPANCY
Howard T.E.	-	GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
Howarth N.	-	USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
Howe N.	-	RISK DETERMINANTS OF ARTERIAL THROMBOSIS INCREASE THE RISK OF INTRAUTERINE GROWTH RESTRICTION (IGR)
Howes J.	-	COMPLEMENT C3 IS A PLASMA CLOT COMPONENT AND INFLUENCES CLOT LYSIS
Howes J.M.	-	PHOSPHOPROTEIN PROFILING OF COLLAGEN PEPTIDE ACTIVATED PLATELETS: A FOCUS ON SERINE AND THREONINE PHOSPHORYLATION EVENTS
Howlettt-Clyne S.M.	-	ACCURACY OF THE COAGUCHEK XS FOR POC INR IN CHILDREN REQUIRING WARFARIN
Hoylaerts M.F.	-	INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION
	-	CATHEPSIN G IS NOT A SPECIFIC AGONIST FOR PROTEASE ACTIVATED RECEPTORS IN PLATELETS
Hoylaerts M.	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
	-	NUTRITIONALLY INDUCED OBESITY REDUCES THE ARTERIAL THROMBOTIC TENDENCY OF FACTOR V LEIDEN MICE
Hoylaerts M.F.	-	DIAGNOSIS OF THE ANTIPHOSPHOLIPID SYNDROME BY CALIBRATED AUTOMATED THROMBINOGRAPHY
Hoylaerts M.	-	THROMBOSPONDIN1 GENE DEFICIENCY ATTENUATES ATHEROSCLEROTIC PLAQUE BURDEN BUT ACCENTUATES INFLAMMATORY CELL PLAQUE CONTENT IN APOE-DEFICIENT MICE
	-	THROMBOSPONDIN1 GENE DEFICIENCY MODULATES VASCULAR MEDIAL SMOOTH MUSCLE CELL ACTIVATION AND NEOINTIMA FORMATION
Hrachovinová I.V.	-	USE THROMBIN GENERATION ASSAY AND THROMBELASTOGRAPHY IN MONITORING OF RESPONSE TO DDAVP IN PATIENTS WITH TYPE 1 AND 2A VON WILLEBRAND DISEASE
Hrachovinová I.	-	MAJOR ABDOMINAL SURGERY IN A PATIENT WITH SEVERE HAEMOPHILIA A AND HIGH INHIBITOR TITRE
Hrachovinova I.	-	Detection of nonmuscle myosin-IIA, inclusions in neutrophils, D-variant of fibulin-1 and mutations within MYH9 gene in patients with MYH9-ralated disorders
Hron G.	-	EXCESS BODY FAT AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM
	-	ENDOGENOUS THROMBIN POTENTIAL IN PREGNANT WOMEN RECEIVING LOW MOLECULAR WEIGHT HEPARIN (LMWH)
	-	CIRCULATING P-SELECTIN AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM
Hsieh L.B.	-	A NOVEL MUTATION IN EXON 10 OF FACTOR XIII SUBUNIT B
	-	FACTOR XIII PHARMACOKINETICS
Hsieh M.C.	-	ELEVATED PLASMA FREE FATTY ACID LEVEL (MYRISTIC ACID, PALMITIC ACID, STEARIC ACID) IN TYPE 2 DIABETIC INDIVIDUAL
Hsu J.	-	CHARACTERIZATION OF VASCULAR ENDOTHELIAL CELLS WITH NULL THROMBOXANE A2 SYNTHASE
HTRS Registry Investigators	-	ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY
Hu Y.	-	PATIENTS WITH LUPUS ANTICOAGULANTS AND HISTORY OF THROMBOSIS CARRY ANTIBODIES TO BETA2-GLYCOPROTEIN I INHIBITING THE PHOSPHOLIPID OXIDATION-DEPENDENT ACTIVITY OF APC
Hu S.	-	PREVALENCE OF VON WILLEBRAND'S DISEASE IN PREMENOPAUSAL WOMEN WITH IRON DEFICIENCY ANEMIA AND MENORRHAGIA
Hu X.	-	EXPRESSION OF MT1-MMP IN HUMAN VASCULAR ENDOTHELIAL CELL LINES AND THE CONSTRUCTION OF ITS EUKARYOTIC EXPRESSION VECTOR
Hu J.	-	INFLUENCE OF BUYANG HUANWU DECOCTION COMBINED UNSATURAT FATTY ACID IN RATS WITH HYPERLIPIDEMIAED
Hu S.	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
Hu J.	-	SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Hua B.	-	VENOUS THROMBOEMBOLISM IN CHINA: A SINGLE-CENTER EXPERIENCE FOR 11 YEARS
	-	PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Huang T.F.	-	ANTIPLATELET AND ANTITHROMBOTIC ACTIVITY OF NP-313, 2-ACETYLAMINO-3-CHLORO-1,4-NAPHTHOQUINONE, A NOVEL CPLA2 AND CYTOSOLIC CA 2 + MOBILIZATION INHIBITOR
Huang H.	-	THROMBELASTOGRAPHY STUDY OF HEMOSTATIC AGENTS
Huang Y.J.	-	A NATURAL EXTRACT FROM PIPER PHILIPPINUM (2R,3R)-2-(3',4'-DEHYDROXYBENZYL)-3-(3"-4"-DIMETHOXYBENZYL)BUTYROLACTONE (PP-6) SUPPRESS FMLP-INDUCED SUPDROXIDE PRODUCTION BY INHIBITION FMLP-RECEPTOR BINDING IN HUMAN NEUTORPHIS
Huang G.S.	-	EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
Huang K.S.	-	EVALUATION OF THE ACTIVITY OF BONE-SPECIFIC ALKALINE PHOSPHATASE AND TARTRATE-RESISTANT ACID PHOSPHATSE ISOFORM 5B IN HEMOPHILIC PATIENTS
Huang S.M.	-	EVALUATION OF THE ACTIVITY OF BONE-SPECIFIC ALKALINE PHOSPHATASE AND TARTRATE-RESISTANT ACID PHOSPHATSE ISOFORM 5B IN HEMOPHILIC PATIENTS
Huang T.F.	-	THE INTERACTION OF KERATINOCYTES AND FIBROBLASTS WITH INTEGRIN ALPHA2BETA1 AGONIST, AGGRETIN, AND ITS REGULATION BETWEEN EPITHELIAL/MESENCHYMAL COMMUNICATION
Huang C.	-	THE REGULATION OF THROMBOMODULIN DISTRIBUTION IN ENDOTHELIAL CELLS
Huang D.C.S.	-	PROGRAMMED ANUCLEAR CELL DEATH DELIMITS PLATELET LIFE SPAN
Huang C.	-	PLATELET PROTEIN DISABLED-2 IS REQUIRED FOR EMBRYONIC STEM CELL-DERIVED MESODERM FORMATION AND MEGAKARYOCYTIC DIFFERENTIATION
Huang S.	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
Huang Y.	-	CD72 POLYMORPHISM ASSOCIATED WITH SUSCEPTIBILITY TO IDIOPATHIC THROMBOCYTOPENIA PURPURA IN CHINESE PATIENTS
Huang M.	-	STRUCTURE OF U-PA/U-PA RECEPTOR COMPLEX
Huang S.	-	PREVALENCE OF VON WILLEBRAND'S DISEASE IN PREMENOPAUSAL WOMEN WITH IRON DEFICIENCY ANEMIA AND MENORRHAGIA
Huang T.F.	-	FCGAMMARII MEDIATES PLATELET AGGREGATION CAUSED BY DISINTEGRINS AND GPIIB/IIIA MONOCLONAL ANTIBODY, AP2
Huang H.	-	SPERM MEDIATED HUMAN COAGULATION FACTOR VIII GENE TRANSFER AND EXPRESSION IN TRANSGENIC MICE
Huang C.	-	THE RGD-CONTAINING PEPTIDE DERIVED FROM PLATELET DISABLED-2 INHIBITS DU145 PROSTATE CANCER CELL-INDUCED PLATELET AGGREGATION
Huang Y.	-	SERUM BAFF LEVELS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Hubbard A.	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
Hubbs-Taan D.	-	PRONOUNCED B KNOB CAPACITY TO MODULATE FIBRIN ARCHITECTURE, STIFFNESS, AND PLASMIN LYSIS
Hubel E.	-	ENHANCED VIABILITY AND EX VIVO EXPANSION AND MATURATION OF CORD BLOOD MEGAKARYOCYTE PROGENITORS (MK-P) WITH FIBRONECTIN
Huber K.	-	IN HUMAN MACROPHAGES THE COMPLEMENT COMPONENT C5A INDUCES THE EXPRESSION OF ONCOSTATIN M VIA AP-1 ACTIVATION
	-	THROMBIN UPREGULATES EXPRESSION OF ONCOSTATIN M (OSM) IN HUMAN MACROPHAGES AND PERIPHERAL BLOOD MONOCYTES
	-	CORONARY INSTENT RESTENOSIS OF DRUG-ELUTING STENTS IS ASSOCIATED WITH SERUM LEVELS OF MMP-9
Hübl W.	-	LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
Hudek R.	-	THE TYPE OF MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME IN RELATION TO THE AGE OF THE PATIENTS
Huetter J.	-	RECOMBINANT FACTOR VIIA PARTIALLY REVERSES THE ANTICOAGULANT EFFECT OF HIGH-DOSE RIVAROXABAN A NOVEL, ORAL, DIRECT FACTOR XA INHIBITOR IN RATS
Huge A.	-	HAPLOTYPES OF THE PROTEIN Z GENE ASSOCIATED WITH SYMPTOMATIC THROMBOEMBOLISM IN CHILDREN
Hughan S.C.	-	IDENTIFICATION OF NOVEL TYROSINE PHOSPHORYLATED SIGNALLING PROTEINS FOLLOWING IIb3-MEDIATED PLATELET SPREADING: INVOLVEMENT OF THE IMMUNOGLOBULIN SUPERFAMILY MEMBERS G6B-B AND G6F, AND THE NOVEL PLATELET ADAPTER DOK-3
Hughes C.E.	-	IDENTIFICATION OF NOVEL TYROSINE PHOSPHORYLATED SIGNALLING PROTEINS FOLLOWING IIb3-MEDIATED PLATELET SPREADING: INVOLVEMENT OF THE IMMUNOGLOBULIN SUPERFAMILY MEMBERS G6B-B AND G6F, AND THE NOVEL PLATELET ADAPTER DOK-3
Hughes G.	-	MAJOR OBSTETRIC HAEMORRGHAGE IN LATE TERMINATION OF PREGNANCY
	-	MAJOR OBSTETRIC HAEMORRHAGE IN LATE TERMINATION OF PREGNANCY
Hughes A.D.	-	CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Hughes C.E.	-	A GADS-INDEPENDENT PATHWAY OF PLCGAMMA2 REGULATION DOWNSTREAM OF THE COLLAGEN RECEPTOR, GPVI
Hui S.R.	-	FUNCTIONAL ELISA OF VON WILLEBRAND FACTOR (VWF) ACTIVITY USING HIS-TAGGED INCREASE-OF-FUNCTION RECOMBINANT GPIB BOUND TO NICKEL CHELATE PLATES
	-	RISTOCETIN-INDUCED AGGREGATION OF HUMAN GPIBALPHA TRANSGENIC MICE IS INHIBITED BY ANTI-HUMAN GPIBALPHA ANTIBODIES IN THE PRESENCE OF HUMAN PLASMA
Huiberts A.A.M.	-	PERIOPERATIVE PROPHYLACTIC DOSING OF TINZAPARIN IN MORBID OBESE PATIENTS
Huisman M.V.	-	HIGH D-DIMER LEVEL INCREASES THE LIKELIHOOD OF PULMONARY EMBOLISM IN A HIGH-RISK POPULATION
	-	DIRECT THROMBUS IMAGING WITH MAGNETIC RESONANCE IN THE DISCRIMINATION BETWEEN ACUTE AND CHRONIC DEEP VEIN THROMBOSIS; A PROSPECTIVE PROOF-OF-PRINCIPLE STUDY
	-	CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
	-	PULMONARY EMBOLISM FAILURE RATE IN PATIENTS IN WHOM PULMONARY EMBOLISM WAS RULED OUT BY LOW AND INTERMEDIATE PROBABILITY BY THE REVISED GENEVA SCORE AND A NORMAL QUANTITATIVE D-DIMER TEST RESULT
	-	HEART-TYPE FATTY ACID BINDING PROTEIN IS PREDICTIVE FOR MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
	-	COMPARISON OF THE REVISED GENEVA RULE WITH WELLS RULE FOR ASSESSING CLINICAL PROBABILITY OF PULMONARY EMBOLISM
Huisman T.A.	-	PORT--CATH-RELATED THROMBOSIS AND POSTTHROMBOTIC SYNDROME IN PAEDIATRIC ONCOLOGY PATIENTS: THE PACTOP STUDY
Huisman M.V.	-	FACTOR V LEIDEN IS ASSOCIATED WITH MORE DISTAL LOCATION OF DEEP VEIN THROMBOSIS OF THE LEG
	-	LABORATORY-DEFINED ASPIRIN RESISTANCE IS ASSOCIATED WITH A HIGHER RISK OF RECURRENT CARDIOVASCULAR EVENTS: A META-ANALYSIS
	-	CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS
	-	HIGH LEVELS OF LDL-CHOLESTEROL AND TRIGLYCERIDES AND SUBOPTIMAL GLYCEMIC CONTROL PREDICT DIMINISHED EX VIVO ASPIRIN RESPONSIVENESS IN PATIENTS WITH TYPE 2 DIABETES
	-	RISK FACTORS FOR MORTALITY THREE MONTHS AFTER PULMONARY EMBOLISM
Huisse M.G.	-	MECHANISMS ASSOCIATED WITH FAILURE OF THROMBOLYTIC THERAPY TO RECANALIZE THE INFARCT ARTERY IN ACUTE MYOCARDIAL INFARCTION
Hulikova M.	-	THE ANALYSIS OF TREATMENT BY rFVIIa IN CARDIO SURGICAL BLEEDING
	-	OPTIMIZING rFVIIa TREATMENT
Hulikova J.	-	OPTIMIZING rFVIIa TREATMENT
Hull R.D.	-	LATE BREAKING CLINICAL TRIAL: EXTENDED-DURATION VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS WITH RECENT REDUCED MOBILITY: THE EXCLAIM STUDY
Hulot J.S.	-	THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS
Hulot J.	-	INFLUENCE OF CYP2C19 AND CYP3A4 GENE POLYMORPHISMS ON CLOPIDOGREL RESPONSIVENESS IN HEALTHY SUBJECTS
Hummel B.	-	FACTOR V LEIDEN PROTECTS AGAINST DIABETIC NEPHROPATHY IN MICE
Humphries J.E.	-	RECOMBINANT HUMAN PLASMIN PRODUCED IN LEMNA MINOR
Humphries S.E.	-	PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY
Hunfeld A.	-	DETERMINATION OF PLASMA COAGULATION FACTOR XIII WITH THE NOVEL FLUOROGENIC ISOPEPTIDASE ASSAY
Hung S.	-	THE INFLUENCE OF THE HEMODIALYSIS PROCEDURES ON PLATELET AND HEMOSTATIC FUNCTIONS
Hunt B.	-	SOUTH EAST ENGLAND THROMBOTIC THROMBOCYTOPENIC PURPURA REGISTRY
Hunt J.	-	IMPORTANCE OF FIBRIN BINDING FOR THERAPEUTIC EFFICACY OF DIRECT THROMBOLYTICS
Hunt S.	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
Hunt S.P.	-	TACHYKININS AND THE NEUROKININ RECEPTOR 1 ARE REQUIRED FOR PLATELET THROMBUS FORMATION
Hunt B.	-	TREATMENT OF IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA WITH MABTHERA (RITUXIMAB)
Hunter R.W.	-	REGULATION OF PHOSPHODIESTERASE 3A IN HUMAN PLATELETS IS MEDIATED BY PROTEIN KINASE C
Huntington J.A.	-	POSSIBLE PLACEMENT OF THE ELUSIVE TAIL OF HEPARIN COFACTOR II REVEALED BY A CRYSTAL STRUCTURE AT LOW IONIC STRENGTH
	-	BIOCHEMICAL CHARACTERISATION OF ANTITHROMBIN BUDAPEST 3 (L99F)
	-	REMOVAL OF THE POSITIVE CHARGE BUT NOT THE HYDROPHOBIC STEM FROM LYSINE-222 IN ANTITHROMBIN III BETA-SHEET-A REDUCES FACTOR XA INHIBITION RATES AND INCREASES HEPARIN BINDING AFFINITY
	-	THE MECHANISM OF ALLOSTERIC ACTIVATION OF ANTITHROMBIN REVEALED BY CRYSTAL STRUCTURES OF ITS MONOMERIC AND FACTOR XA-COMPLEXED FORMS
	-	SERPINS IN THROMBOSIS, HEMOSTASIS AND FIBRINOLYSIS
	-	THE ANTITHROMBIN III SERINE-380 P14 HYDROXYL MAKES CRITICAL CONTRIBUTIONS TO METASTABILITY OF THE NATIVE CONFORMATION AND TO STABILIZATION OF THE HEPARIN-BOUND ACTIVATED STATE
	-	THROMBIN IS A ZYMOGEN-LIKE ENZYME
	-	STRUCTURE OF NATIVE PROTEIN C INHIBITOR PROVIDES INSIGHT INTO ITS MULTIPLE FUNCTIONS
Huntsman D.G.	-	MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
Huo M.	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
Hupuczi P.	-	STUDY OF THE METHYLENETETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM IN HELLP SYNDROME PATIENTS
	-	THE OCCURRENCE OF FACTOR V LEIDEN MUTATION IN HUNGARIAN HELLP SYNDROME PATIENTS
Hurn P.D.	-	PROTEIN C ACTIVATOR (PCA) TREATMENT IMPROVES THE NEUROLOGICAL OUTCOME OF EXPERIMENTAL THROMBOTIC ISCHEMIC STROKE IN MICE
Hurst S.	-	PROTEIN C ACTIVATOR (PCA) TREATMENT IMPROVES THE NEUROLOGICAL OUTCOME OF EXPERIMENTAL THROMBOTIC ISCHEMIC STROKE IN MICE
Hurtaud-Roux M.F.	-	IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
Hussain S.	-	BAYESIAN STATISTICAL MODELLING OF PATIENTS INR RECORDS USING REPEATED MEASURES MODELS AND INDIVIDUAL TIME SERIES
Hussaini B.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Husvéth Á.	-	HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
Huszcza S.	-	A PROSPECTIVE EFFICACY AND SAFETY STUDY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED FACTOR VIII ADMINISTERED BY CONTINUOUS INTRAVENOUS INFUSION IN SEVERE HAEMOPHILIA A PATIENTS UNDERGOING MAJOR SURGICAL PROCEDURES (PERFACT STUDY)
Hutabarat R.M.	-	PHARMACOKINETIC PROFILES AND PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIP OF A VWF INHIBITORY APTAMER IN THE CYNOMOLGUS MONKEY
Hutabarat R.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
Hutabarat R.M.	-	PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
Hutchaleelaha A.	-	INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
Hutchins R.	-	BCL-2 AND BCL-XL EXPRESSION IN HUMAN CHOLANGIOCARCINOMA CELLS
Huth B.	-	INACCURACY OF POINT-OF-CARE (POC) WHOLE BLOOD INR AT INR VALUES GREATER THAN 4
Huth-Kühne A.	-	SUCCESSFUL INHIBITOR-ELIMINATION W ITH RITUXIMAB IN ONE PATIENT WITH A CARRIER STATE FOR HEMOPHILIA A AND 4 PATIENTS WITH ACQUIRED HEMOPHILIA A
Hutner K.	-	INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS
Hutten B.A.	-	QUALITY OF ORAL ANTICOAGULANT TREATMENT AND RISK OF SUBSEQUENT RECURRENT THROMBOEMBOLISM IN PATIENTS WITH DEEP VENOUS THROMBOSIS. A PROSPECTIVE COHORT STUDY
Hutyra M.	-	AGGREGATION TEST FOR DETECTION CLOPIDOGREL RESISTANCE
Hvas A.	-	THROMBOPHILIA RISK FACTORS ARE ASSOCIATED WITH PREGNANCY RELATED THROMBOEMBOLISM
Hwang E.	-	THE ORAL DIRECT THROMBIN INHIBITOR, DABIGATRAN ETEXILATE, IS EFFECTIVE AND SAFE FOR PREVENTION OF MAJOR VENOUS THROMBOEMBOLISM FOLLOWING MAJOR ORTHOPEDIC SURGERY
Hwang J.	-	POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
Hwang B.	-	POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
Hynes R.O.	-	CELL-MATRIX ADHESION IN VASCULAR DEVELOPMENT
	-	IMPAIRED ANGIOGENESIS AND ENHANCED INTRACRANIAL VASCULAR APOPTOSIS IN A MURINE MODEL OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAITP)

| ISTH 2009